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ABSTRAr,T 
Ventricular fibrillation ls one of the primary 
causes of early sudden death associated with myocardial 
infarction (Lown ~ ~ 1g59). Although Bell et.!!.!. gJ_,_ 
1972) have shown that caffeine infusion increases 
susceptibility to ventricular fibrillation in the dog, 
the question of the effect of daily caffeine consumption 
on cardiac vulnerability remains unanswered. 
Retrospective clinical studies examining the assoc Tat ion 
of coffee consumption on heart disease cloud the long 
term effect of caffeine on cardiac vulnerahil lty to 
arrhythmia in that they are often complicated by 
differences i n each group's level of cigarette smoking, 
blood pressure, 
effects of long 
susceptibil lty of 
was examined. 
body weight, etc. In this study the 
term caffeine administration on the 
the heart to ventricular fibrillation 
Vulnerabil tty to cardiac arrhythmia in the adult 
male rat was determined by measuring the ventricular 
tachycardia threshold (VTT). The VTT was used as an 
index of the vulnerabil tty of larger hearts to 
fibrillation. It was defined as the minimum current 
necessary to generate sustained ventricular tachycardia, 
and was tested by applying trains of pulses directly to 
the right ventricular epicardium through bipolar platinum 
electrodes. The tratn consisted of constant current, 70 
Hz, monophaslc, 2 msec rectangular pulses. It was 
delivered 10 msecs after the right atrial pactng pulse 
and lasted 90 msecs so as to end before the apex of the T 
wave of the electrocardiogram. 
In rats receiving a stngle oral injection of 
caffeine (30 or 90 mg/kg) VTT was 25 per cent lower than 
the VTT of water injected rats (p <0.05). The oral 
injection of water reduced VTT by 35% when compared with 
untreated controls. The caffeine related reductlon was 
in addition to that associated wtth the tnjectlon 
process. Corresponding tachycardia suggested that the 
injection process, in addition to the caffeine 
administration, was associated with sympathetic discharge 
which presumably medl~ted the reduction in threshold. 
Daily or.al treatment with caffeine (in the same 
doses) for 2,4,8 or 10 weeks caused a time related 
reversal of the acute effects of caffeine injection. 
Following 2 or 4 weeks of treatment, acute caffeine 
administration no longer was associated with a reduction 
in VTT. After 8 or 10 weeks of chronlc caffeine 
administration, acute caffeine injection was associated 
with thresholds more than twice as great as water treated 
controls. This relative increase In VTT following 
chronic caffeine was dose dependent. The increase in VTT 
following chronic caffeine admini~tration was the same 
magnitude whether the rat was injected just prior to VTT 
I i 
testing with water or with caffeine. 
Caffeine injection (90 mg/kg/day, p.o.) for a 
period of 10 weeks attenuated the maximal chronotropic 
effect of isoproterenol. This result suggested a 
reduction in cardiac beta adrenerglc receptor 
concentration. The reduction Jn the vulnerabll Jty of the 
rat ventricle to tachyarrhythmia associated with chronlc 
caffeine administration, may be due to the same reduction 
In the cardiac adrenergic receptor population. 
; r i 
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INTRODUCTION 
Paul _g_t ~ examined the relationshfp between 
coffee consumption and the incf dence of coronary heart 
disease (CHO) in 1963. Since then, there has been a 
continufng controversy over the adverse effects of coffee 
lntake on the incidence of CHO and its subsequent 
lethality. Problems inherent to clinical studies such as 
subject selection and uncontrolled varfables seem to be 
responsible, at least in part, for the often conflicting 
results concernfng this relat ionship. In the more than 
half dozen clinical studies found i n the 1 iterature since 
the early 1960's, the risk factor of CHD associated with 
coffee consumption has ranged from no increased risk 
(Dawber, Kanne'l and Gordon, 1974) to a two fold increase 
In the risk of acute myocardial fnfarction (Ml) seen in 
coffee drinkers (greater than s i x cups per day) as 
compared to non coffee drinkers (Jick et~ 1973). The 
motivation for this laboratory study was to examine, in 
part, the overall question of the effect of coffee 
consumption on mortality due to sudden card i ac death. 
Strict controls used in laboratory studfes were adhered 
to, with the intent of avoiding some of t he difficulties 
confounding the clinical studies. 
It is known that the majorfty of persons dying from 
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acute Ml do so suddenly prior to hospitalization (Kannel 
g,t. ~ 1975). Furthermore, in studying this disease 
state, Lown and his co-workers (1 969) have suggested that 
ventricular fibrillation (VF) is one of the primary 
causes of early sudden death associated with Ml. 
It has also been reported that sudden death due to 
arrhythmia (generally V.F. or cardiac arrest) is often 
seen even in those subjects with no overt pathological 
evidence of acute Ml (Roberts and Buja, 1972). As a 
result it 
susceptible 
is not possible to predict which people are 
to this terminal event based solely on the 
status of their coronary circulation. 
To understand the magnitude of this problem, it 
must be pointed out that estimates of the incidence of 
sudden death, without regards to etiology, ranges as high 
as 30 per cent of all deaths (Kannel .fil:. ~ 1975). 
Accordlngly it seemed important to determine what effect 
caffeine, the often touted pharmacologically active agent 
in coffee, would have on the susceptibility of the heart 
to ventricular fibrillation. 
Bellet anrl his co-workers studied caffeine's acute 
effect on cardiac vulnerabll ity in t he dog (Bel let .fil:. 
~ 1972). Their results demonstrated that an acute 
intravenous caffeine injection could si gnificantly 
increase vulnerability by 30 per cent. Furthermore this 
caffeine induced increase Jn susceptibility to VF could 
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be seen even in dogs whose vulnerablllty had already been 
increased by coronary artery 1 igation. Thus, the 
additive effects of acute Ml and acute caffeine 
administration would presumedly predispose the subject to 
spontaneous VF and sudden death. 
For two reasons the relevance of the acute 
intravenous effect of caffeine to the clinical situation 
seems less dlrect than has been lnferred by Bellet and 
his 
tends 
time. 
co-workers. Firstly, caffeine consumption in man 
to occur on a dally basls for prolonged periods of 
Thus a chronic study would more closely 
approximate the clinical 
normally Ingested orally, 
state. Secondly, caffeine Ts 
and not via the intravenous 
route. Based on these considerations the present 
lnvestigation specifically set out to examine the effects 
of chronic oral caffeine administration on cardiac 
susceptibility to ventricular fibrillation. It was also 
of interest to examine the time course as well as the 
dose 
study 
dependency of the caffeine effect. Finally this 
examined whether caffeine's effect on cardiac 
vulnerability was related to any alteratlon of the 
cardiac catecholamine system. 
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RE'JIEVJ OF THE LITERATURE 
To understand the significance of the experlmental 
portion of this thesis, certain background information 
must be presented to orient the reader. The goal of this 
work is, firstly to determine whether or not caffeine 
alters cardiac vulnerability to ventricular fibrillatTon, 
and secondly to study possible mechanisms of such an 
effect. Certain questions come to mind even before 
designing and performing these experiments. What is 
ventricular fibrillation and what is its practical 
signlficance? How has fibrillation been studied In the 
past? By what mechanisms does the heart become 
vulnerable to fibrillation? How can vulnerability be 
quantified? What factors are known to affect 
vulnerability? How might caffeine affect susceptibil lty 
to VF? The intent of this review Is to present 
historical 
questions. 
information which, in part, answers these 
page 5 
F i b r i 1 1 at ion 
Fibrillation has been defined as chaotic, 
asynchronous, fractionated activity of the heart (Moe, 
Ablldskov and Han, 1964). Brooks ~ .2-Ls. (1955) more 
graphically described the state as one in which groups of 
muscle fibers appear to " ••• contract independently of 
adjacent segments of the myocardium, impartlng a 
vermicular movement to the chamber walls". Ventrlcular 
fibrillation (VF) was first descrtbed Jn the sclentlfic 
literature in 1842 by Erlchsen, but was not named 
fibrillation until 1874 when Vulpian first used the term 
"movement flbrillaire" to describe the arrhythmia in the 
dog. 
Gross . observations of the heart Jn which VF ls 
being ini"tlate'd suggests that its inception is not 
necessarily an al 1-or-none state. The arrhythmla may 
initially involve large sections of the heart and then 
progress by a fractionation of activity into smaller and 
smaller independently contracting areas (Brooks~~ 
1955). Certainly, once the heart sustains true 
fibrillation, no single pacemaker initiates coordinated 
excitation and contraction of the myocardium. 
Garrey (1914) proposed the historic concept that VF 
was initiated by differences Jn excitability and 
conrluction in different parts of the myocardium. The 
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Importance of this physiological asymmetry in promottng 
and maintaining this arrhythmia has been reiterated by 
numerous authors since first stated. In terms of 
specific electrophysiologic mechanisms involved in the 
initiation of fibrillation, there have been two basic 
theories since the time of Garrey. The first was 
Garrey's clrcus movement concept which postulates the 
irregular reentry of impulses. Alternatively, Engelman 
(1896) and later Rothberger and Winterberg (1914) 
proposed that ectopic focal stimulation arising from 
multiple foci, or a slngle focus Initiated the 
fibrillation. Evidence supporting both of these 
mechanisms has accumulated over the past sixty years both 
from cl lnical and laboratory studies. Although the 
simple circus movement theory was attacked by Prlnzmetal 
tl 1Ll...a_ (1.952), both theories have prevailed to the 
present as evidenced by their review in monographs by 
Brooks tl .a.L.. (1955) and Surawlcz (1971). 
Part of the reason for the continued acceptance of 
both of these constructs is the severe difficulty in 
identifying specific mechanisms causing fibrillation. 
Surawicz (1971) lists three reasons for this difficulty: 
(1) the lmpossibil ity of local izlng the fiber or group of 
fibers in which the first wave of reentry begins; (2) the 
fact that in many types of experimentally Induced 
fibrillation the onset seems to be due to a combination 
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of factors; and (3) the 11mited number of studles in 
which all cardlac and extracardiac factors which might 
have contributed to the arrhythmia, were studied 
simultaneously. In any case, the present over-riding 
opinion held by cardiac investigators is that initiation 
of fibrillation is caused by a comblnation of these two 
factors. 
The initiation and continuation of VF presents a 
clearly severe threat to the 1 ife of the intact antmal. 
Cessatlon of effective pumping by the heart is seen in 
ventricular flbrillatfon as evidenced by a reduction in 
cardiac output to near zero. Consequently, perfusion 
pressure to the vital organs is severely decreased 
causing mortality. 
Vulnerability to Ventricular Fibrillation 
According to Surawicz (1971), there are three basic 
conditions which must be met for the initiation and 
maintenance of VF. They are: (1) the presence of some 
stimulus to initiate the disorder; (2) a disparity in the 
relation between conduction velocity a nd refractory 
period duration within different parts of t he myocardium 
to foster reentry; and (3) the presence of a critical 
mass of myocardium to malntain the fractionated activity. 
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Notably these criteria are in keeping with the orlginal 
concepts that VF ls initiated by a combination of 
reentrant and ectopic pacemaker activity. 
~Excitable Stimulus 
Ventricular fibrillation is almost universally 
preceded by an acceleration of ventricular rate and/or a 
premature stimulus. The excitable stimulus can therefore 
be any event which aids in the initiation of such 
premature stimuli or ln the acceleration of rate. 
Increased automaticity, whether it be related to 
known pacemaker fibers or nonpacemaker tissue which 
aquires pacemaker activity, is one accepted mechanism of 
premature extrasystole genesis. The ability for normally 
initiated impulses to reenter in a repolarized portfon of 
the ventricle Is a second manner in which premature 
ventricular beats may develop. 
Regardless of the mechanism by which these 
premature sys~oles occur, the moment at which they occur 
ls crucial to their ability to initiate fibrillation. 
This was realized as early as 1920 by De Boer, who 
demonstrated that a single shock, when applied near the 
end of mechanical systole could initiate fibrillation in 
the frog's ventricle. Then, in 1934, King demonstrated a 
similar finding in the dog and went on to show that the 
shock had to fa 11 du r r ng the Q-T i nte rva 1 of the 
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electrocardiographic cycle to initiate the arrhythmia. 
Much later, Smirk and Palmer (1960) reported that 
premature ventricular beats CR waves) which fnterrupted T 
waves of patfent's electrocardiograms could initiate VF. 
This R on T phenomena and its electrophysiologic 
basis in relation to the cardiac vulnerable period wfll 
be df scussed later in this review. Sufffce it to say for 
now that a ventricular extrasystole fall Ing during this 
interval fs capable of el letting the arrhythmia. 
The inftiation of ventrfcular tachycardla and fts 
conversion to fibrillation ts obviously a second course 
of events leading to VF. The electrocardiographic 
differences between tachycardia, flutter and fibrillation 
indicate a progressive desynchronizatfon of electrical 
depolarization and repolarization of the ventricles. 
Tachycardia exhibits distinct ventricular depol~rfzatfon 
and repolarization in the vectorcardfogram, whereas 
flutter demonstrates the simultaneous occurance of these 
events i.e. reflecting reentrant activity (Smfrk _g_t_ 
aL.....c. 1964). The conversfon from flutter to VF fndicates 
a change in the character of the reentrant activity; from 
that of a rhythmic reexcltation following a circumscribed 
pathway, to one of a total arrhythmic activity following 
no prescribed path. 
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lL. Factors Favoring Reentry 
Excitable stimul l, whether they be ventrlcular 
premature beats or ventricular tachycardia, will not 
initiate VF unless the ventricles are Jn a sufficiently 
nonhomogeneous state of electrical activity to sustain 
asynchronous reentry. Premature beats must fall durfng 
the vulnerable perlod to initiate the arrhythmia. That 
Ts not to say that al 1 premature ventricular beats 
(PVB's) occuring during thls period will cause 
fibrillation; however PVB's which occur outside the 
vulnerable period virtually never inltfate VF. The basis 
for the exlstance of the vulnerable period is that during 
this portion of the cardiac cycle there is sufficient 
inhomogeneity to allow the propagated extrasystole to 
undergo multiple reentry. The conversion of tachycardia 
to flbrillatio~ is also due to increased lnhomogeniety 
withln the heart whlch, in turn, increases susceptibil fty 
to reentry. 
The inhomogeniety alluded to Jn this discussion 
relates speciflcally to lnhomogeniety of conduction 
velocity and/or refractory perlod duration ln different 
portions of the heart. Those factors that increase that 
spatial disparity increase the 1 ikel ihood of reentry and 
arrhythmogenesis. 
A disparity 
ventricles is seen 
of conduction veloclties wfthln the 
in the normal heart. Purkinje fibers 
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conduct at the very fast rate of 2 - 4 meters/second, 
whereas neighboring ventricular muscle conducts at a rate 
of only 0.5 to 1 meter/second. Factors that slow 
conduction velocity, particularly of the muscle fibers, 
are notorious for fostering reentry. These include 
increased extracellular potassium concentratlon, stretch, 
electrical stimuli, myocardial ischemia, etc. 
Furthermore, premature beats tend to conduct more slowly 
than do normal beats, as a result of their slower rate of 
phase O depolarization. By abruptly slowlng the 
conduction of the impulse once it reaches a depressed 
portion of the myocardium, It is posslble for those cells 
bordering this zone to become reexcitable while the 
slowly traveling wavefront is still close enough to 
reexcite them. 
lmpl icit in the phenomena of reentry is that lt can 
only occur in tissue that has regaTned its excitabil Jty. 
Just as there are inherent differences in conduction 
velocities in different parts of the normal heart, there 
are differences in the duration of the refractory periods 
at various sites (Han and Moe, 1964). Moe~ .QJ_._ (1955) 
have suggested that vulnerabll ity to fibrillation, as a 
result of reentry, may have as its basis normal 
differences of action potential duration and the 
asynchrony of repolarlzation of neighboring Purklnje 
fibers and muscle tissue. These differences Jn 
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refractory period duration cause the conducted excitation 
wavefront to travel down the repolarized fibers prior to 
exciting those fibers with longer refractory periods. 
This difference in action potentlal duration 
between Purkinje fibers and neighboring ventrlcular 
muscle fibers has been shown to be dependent on heart 
rate. Moore ~.ala. (1965) reported that at rapid heart 
rates this difference ls minimal, whereas at slower 
rates, action potential durations of the Purkinje fibers 
tend to lengthen dramatically relative to those of the 
muscle tissue. 
Temporal dispersion of recovery of excitability has 
been directly measured by Han and Moe (1964) and again by 
Han stt. ~ (1966a), Spear stt. ~ (1973) and numerous 
other investigators. The work by Han stt. ~ (1966a) 
again demonstrited that this dispersion of refractoriness 
was inversly related to heart rate. Agents known to 
increase the dispersion of refractoriness include 
sympathetic stimulation, ischemia, chloroform, toxic 
doses of ouabain (Han and Moe, 1964; Han~~ 1964). 
Studies such as these, relating to temporal dlspersion of 
recovery have taken on a major sl gniflcance in that these 
investigators have correlated this dispersion of recovery 
with an increased susceptibi l ity to fibrillation (see 
Assessment of Vu l nerability to Fibrillation, Electrical 
Fibrillation Threshold subsection). 
page 13 
Premature beats increase susceptfbtl i ty to VF by 
fostering reentry. Thelr slow conductlon rate, thelr 
prolonged vulnerable perfod (Wegrfa tl ~ 1941) and 
their abil lty to increase the temporal dispersion of 
refractoriness (Han and Moe, 1964) are a l l 
characteristics which promote reentry. 
A proposed mechanism explainlng the progressive 
desynchronization of ventricular tachycardia to VF Is the 
multiple wavelet hypothesfs developed by Moe and 
Abtldskov (1959). In that proposal, premature 
reactlvation increases the normal asynchrony Jn the 
recovery phase of excitability among adjacent fibers. In 
tachyarrhythmias the increased incidence of premature 
reactivation becomes so great as to set up adjacent areas 
of totally refractory tissue bordering potentially 
excftable fibe'rs. These potentially excitable fibers 
border other refractory areas. This gross disparity of 
electrical status in adjacent tissue allows for multiple 
reentry of a conducted beat to occur, which could then 
initiate the fibrfllatfon. 
In summary, a 11 hearts have a ce rta 1 n degree of 
intrinsfc fnhomogenefty of conduction velocfties and 
duration of refractoriness. Increas i ng t hat 
inhomogeneity fosters reentry, and correspondingly 
increases the susceptibility to arrhythmogenesis. 
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~Critical Myocardial Mass 
Garrey, in his pioneering studies on fibrillation 
(1914), realized the importance of a critical myocardial 
mass in both the initiation and maintenance of the 
arrhythmia. In the 62 years since Garrey's report, 
numerous investigators have supported the finding that 
hearts of small animals are relatively immune to 
procedures inducing VF in larger species. Recently, 
Ederstrom (1976) reported that VF could not be Initiated 
in ventricles with a surface area less than 10 square 
centimeters regardless of the age of the animal. 
Furthermore, persistant VF did not develop in ventricular 
tissue in which myocardial density was small (i.e. when 
the surface area/gm was greater than 3.50 square 
centimeters). Conversly when surface area/gm was 1.50 
square centimeters or less, fatal VF could always be 
induced. These results suggest that not only is a 
critical mass required to initiate and sustain the 
arrhythmia, but also an adequate surface area and 
myocardial density is required for arrhythmogenesis. 
Presumedly the necessity for the mlnimal density, 
surface area and mass to allow for flbrlllatlon is 
related to the heart's ability to sustain reentry. This 
supposition was supported by the fi~dlngs of Wes~ and 
Lauda (1962). They demonstrated that the minimal weight 
of atrial tissue in which sustained arrhythmia could be 
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produced was equivalent to that theoretically required to 
maintain reentry. 
Assessment of Vulnerabil lty to Ventricular Fibrillation 
Historically, to assess the vulnerabfl ity of the 
heart to VF it has been necessary to experimentally 
produce fibrillation. There are presently numerous 
techniques for inducing the arrhythmia. The use of each 
of them not only provides information as to the 
vulnerability of the heart to VF, but also sheds 1 ight on 
the pathophysiologlc mechanisms involved In the genests 
of the dysrhythmia. Depending upon the nature of the 
questlon under study, a given method of initiating the 
arrhythmia will perhaps be more appropriate than another 
method. As a result, the abundance of arrhythmogenlc 
techniques has practical significance. In that the major 
Interest of this research was to determine whether a 
given drug treatment altered the susceptibility of the 
heart to arrhythmia, the major criteria In choosing the 
method for measuring vulnerability was its quantitative 
nature. A second criteria In this choice was the 
strength of the method as a model of in vivo 
arrhythrnogenesis and sudden cardiac death. Faced with 
those goals, the following review of the major techniques 
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utilized in assessing vulnerability was undertaken. 
~Non - Electrical Techniques 
Szekeres and Papp dfscuss in their monograph (1971) 
the various methods for inducing experimental 
arrhythmias. The non-electrical techniques can be 
outlined as fol lows: 
1. Drugs or other chemical agents. 
a) applied locally to the heart (i.e. aconftine, 
delphinine, mecholyl, veratrine or potassium salts) 
b) administered through the blood stream 
(i) as a single drug (large doses of 
antiarrhythmic agents, veratrine alkaloids, 
cardiac glycosides, Ba Cl2, Ca Clz) 
(ii) a combination of various drugs - i.e. 
catecholamines plus sensitizing agents 
(cyclopropane, chloroform, halothane, benzene, 
etc.) or chol fnergic agonists plus either 
sensitizing agents or hormones 
(if i) drug administrations combined with 
electrical stimulation 
2. Mechanical or thermal disruption of normal cardiac 
electrophysiological activity. 
a) coronary artery ligation and other mechanical 
techniques which cause ischemia 
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b) local cooling or heatfng of the myocardium 
3. Excitation of the central nervous system (CNS). 
a) electrical stimulation of the CNS 
b) intraventricular drug administration (e.g. 
acetylchol ine, nicotine, caffeine, analeptics, 
tryptamine, KCl, and strophanthidin) 
c) mechanical increase in intracranfal pressure 
As early as 1875 Boehm demonstrated that injectlon 
of barium chloride could produce cardiac arrhythmia. 
Later, Levy (1911) demonstrated that under 1 f ght 
chloroform anesthesia, epinephrine could initiate VF. 
It was not until the late 1930 1 s, however, that 
fibrillatory agents were used to quantltatively assess 
the vulnerability of the heart to arrhythmia. Meek and 
his co-workeri (1937) used test doses of epinephrine to 
assess vulnerability of dog heart to arrhythmia after 
treating the animals with several different volatile 
anesthetics. Shen and Simon (1938) seem to be the first 
investigators, using non-electrical technlques, to 
demonstrate a reduction in susceptibil tty to VF after 
treatment with an antiarrhythmlc agent, namely procaine. 
Blumenthal and Tribe - Oppenheimer (1939) suggested that 
a quantitative assessment of vulnerability could be made 
by determinin g the amount of barium chloride whtch was 
just sufficient to fibrillate the perfused cat's heart. 
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Since the work of these early investigators, the use of 
non-electrical techniques have proved to be very useful 
as a means of studying both the pathophysiology of VF and 
the heart's susceptibility to the arrhythmia. 
Mechanistically, the use of these non-electrical 
techniques relate to their capabillty to increase cardiac 
automaticity and/or to increase the abil fty of the heart 
to sustain reentry. Aconotine, first used by Scherf 
(1947), increases automaticity when topically appl led to 
the epicardium (Schmidt, 1960 and Matsuda~~ 1959). 
Numerous authors have suggested that increased sodium 
conduction is responsible for this drug's increase in 
automaticity. Alternatively, locally appl led 
chol lnomimetics seem to initiate arrhythmia by increasing 
reentry (West and Lauda, 1962). Veratrine both increases 
spontaneous ac~ivity and, by means of slowing conduction 
rate, fosters reentry. 
The usefullness of these non-electrical techniques 
relates to their ability to model naturally occ·ur i ng, in 
vivo, arrhythmogenesis. Partfcularly relevent to this 
issue is the use of catecholamines in combination with 
volatile sensitizing agents to mimic arrhythmia 
development during 
ligation is useful 
arrhythmogenesis. 
gaseous anesthesia. Coronary artery 
in representing l schemic 
Furthermore, cardiac glycoside 
induced dysrhythmia directly relates to clinically 
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observed arrhythmia seen in dlgltal Ts toxicity. 
Other non-electrical methods, however, do not offer 
acceptable models of in vivo arrhythmogenesis. For 
example, application of drugs directly to the epicardium 
is a totally non-physiologic phenomena. This 
disadvantage is overwelghed, in some cases, by other 
advantages of the method; in particular the long duration 
of the elicited arrhythmia once it is initiated. 
Prolonged arrhythmias are particularly useful in studying 
the efficacy of antlarrhythmics in terminating on-going 
dysrhythmias. 
The protocol related to the use of these techniques 
in assessing vulnerability obviously depends on the 
specific technique. For example, Jn using the technique 
of the direct application of a drug to, or mechanical 
alteration of the myocardial surface, the latency to 
arrhythmia would be an appropriate measurement. The use 
of intravenous drug administration, either as the only 
arrhythmogenic agent or in combination with other agents 
which facilitate dysrhythmia (e.g. volatile anesthetics), 
could be quantified by measuring the dose of the drug 
required to initiate the arrhythmia. Similarly, 
excitation of the CNS with drug administration could be 
measured according to the dose administered. 
In discussing the actual use of any technique to 
assess cardiac vulnerability, its ease of development and 
appl tcation has 
Injection of an 
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practical importance. The Intravenous 
arrhythmia-inducing agent to an 
anesthetized anfmal 
Depending on the 
is a very straight forward procedure. 
species being studied, the 
administration of a gaseous sensitizing agent may be 
either simple or somewhat involved. In general, though, 
the development of non-electrical techniques to assess 
cardiac Trrltabil Tty present far less technological 
difficulties than does the development of electrical 
techniques. 
Disadvantages of non-electrical techniques, 
however, often preclude their use in certafn studies. If 
Tt is of interest to study the effect of a drug on the 
susceptibil Tty of the heart to an arrhythmia, then to 
assess that susceptibll ity with a combination of other 
drugs (e.g. epinephrine plus a volatile anesthetic) could 
complicate the results due to the possfbil ity of drug 
interactions. A second difficulty in using 
non-electrical techniques to assess drug effects on 
vulnerabll tty ls the inability of these techniques to 
continually follow the time course of the effect of the 
drug under study. This problem has particular relevence 
to this thesis in that numerous sympathetfc agonists as 
well as aminophyll ine have been shown (using electrical 
threshold techniques to measure vulnerability) to 
initially increase susceptibility to VF, but then within 
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a matter of minutes to decrease that susceptlbil ity (Han 
_g_t ~ 1964 and Moore and Spear, 1975). Finally, It is 
the nature of the non-electrical techniques that the 
arrhythmias they initiate are not readf ly reversible. 
Again, depending upon the question under investigation, 
this characterlstic can either be an advantage or 
dlsadvantage. 
JL. Electrical Fibrillation Threshold Technlques 
The electrical fibrillation threshold ls the 
minimal current required to induce cardtac flbrillatfon 
(Szekeres and Papn, 1971). The concept of using the 
strength of an electrical stimulus as a measurement of 
susceptfbfl ity to VF was ff rst Introduced by Einbrodt 
(1859). For more than 75 years after Einbrodt's work, 
this 
1932, 
technique 
rekindled 
found 1 ittle or no use. 
its use as a means 
Then Levine, in 
of assessing 
vulnerability. Even prior to the time of Einbrodt, 
however, the use of e 1 ect r i ca 1 st i mu 1 i to 1 nduce 
fibrillation had been used; that ls dating back to the 
work of Hoffa and Ludwig (1850). 
During the Nineteenth Century and the early 
Twentieth Century, investigators usfng electrical shock 
to initiate dysrhythmia used prolonged shocks (lasting on 
the order of seconds). Presumedly these early workers 
used long-lasting shocks since shorter shocks, when 
page 22 
delivered haphazardly during the cardtac cycle, were 
incapable of consistently eliciting VF. De Boer 
(1920-1921) first demonstrated that a brief induction 
shock applied near the end of systole to the ventricle of 
the exsanguinated, hypodynamic, frog heart could Initiate 
a condition similar to fibrillation. Ferris and 
co-workers (1936) then reported that delivering a 30 
msec. shock during the relative refractory period, 
corresponding to the T wave of the electrocardiogram, 
could el iclt VF in the normally functioning dog heart. 
These findings suggested that there was a 'vulnerable 
period' of the cardiac cycle during which brief 
electrical shocks of relatively small strength could 
initiate ventricular fibrillation. It remained for Carl 
Wiggers, Rene Wegria and their co-workers at the Western 
Reserve Medical School to further develop a sufficient 
understanding of this vulnerable period so as to be able 
to propose a quantitative fibrillation threshold needed 
to assess vulnerability to VF in the intact dog heart. 
In a series of three papers in 1940 (Wiggers and 
Wegria, l940a; Wegria and Wiggers, 1940a; and Wegria and 
Wiggers, 1940b) these investigators demonstrated that 
brief (10-40 msec.) condenser or induction shocks could 
consistently initiate VF when del i vered during the late 
portion (the last 60 msec.) of mechanical systole. This 
period, entitled the vulnerable per iod, corresponded with 
that of 
(1936). 
both De Boer 
F i b r i 1 1 at i on 
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(1920-1921) and Ferrfs ~ .aL.. 
never developed when a shock of 
similar strength was delivered during any other portion 
of the cardiac cycle. Unlike the study of Ferris ~ gJ_._ 
(1936), the fibrillation initiated by Wiggers and Wegria 
(1940a) required electrical stimulation of only a 
localized region of the myocardium. Understandably, this 
finding had implications on the mechanfsm of electrically 
induced VF. Furthermore Wiggers and Wegria reported that 
rectangular, monophasic, electrical shocks that lasted SO 
90 msec., were capable of el fciting VF only when 
delivered such that they were initiated or terminated 
during the vulnerable period. Longer D.C. shocks 
(100-140 msec.) could initiate fibrillation, assuming the 
shock was of sufficient energy, If initiated or 
terminated during the vulnerable period of a normally 
propogated beat or a premature contraction. Sixty cycle 
per second alternating current (A.C.) showed similar 
responses as did D.C. stimulation, except that prolonged 
A.C. stimulation (greater than 7 cycles) often initiated 
VF when the A.C. stimulus was initiated just after the 
vulnerable period (i.e. early diastole), whereas this was 
quite a rare occurance for D.C. shocks. The explanation 
of this particular finding lay In the fact that late A.C. 
cycles were apt to fall du~ing the vulnerable period of 
previously developed premature contractions. Aga l n, 
shocks initiated or terminated 
period of any conducted beat 
sufficient strength. 
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during the vulnerable 
could produce VF If of 
Following these preliminary studles, Wiggers and 
Wegria (1940b) proposed and tested their fibrfllation 
threshold technique. The method consisted of measuring 
the minimal current strength of brlef (10-30 msec.) D.C. 
shocks which could initiate VF, when delivered, to any 
fixed region of the ventrlcular epicardium, during the 
vulnerable period. To maintain consistent thresholds in 
the same preparation, over time, it was determined 
necessary to defibrillate the heart within 30 seconds, 
maintain the animal's blood temperature within one to two 
degrees centigrade, use non-polartzable electrodes (e.g. 
platinum or silver-silver chloride), continually change 
the polarity of the stimulating current to further 
minimize polarization effects, and finally to allow at 
least 15 minutes between fibrillation and retesting. 
Using the technique, these investf gators demonstrated an 
increase ln the ventricular fibrillation threshold (VFT) 
in dogs treated with procaine (8-10 mg/kg) (Wiggers and 
Wegria, 1940b). Also, it was demonstrated by \1/iggers tl 
.9.l...t.. (1940), that using this fibrillation threshold 
technique it was possible to show an increase In 
susceptibility to VF associated with myocardial ischemia. 
Since first being proposed as a method of 
page 25 
quan~tfying cardiac susceptibility to arrhythmia, 
electrical threshold measurements have found wide spread 
use; Presently there are three basic methods for VFT 
measurement using electrical stimulatlon. They are (1) 
the single shock method, (2) the alternating current 
method and (3) the trafns-of-pulses method. 
1) The single shock method 
Historically the first acceptable quantitattve 
method for VFT determination was the single shock method 
as proposed and refined by Wiggers and Wegria. In this 
method a single, monophasic, rectangular pulse of 2-30 
msec. duration is applied to the heart during late 
systole. The pulse is delayed further and further into 
the S-T segment until passing the T wave. It is then 
Increased in amplitude and again the S-T segment is 
scanned until eventually fibrillation ensues. 
The appl fed current initiates a premature beat when 
delivered at subfibrillatory amperage during the 
vulnerable period (Wegria and Wiggers, l940a). When 
stimulating current is increased, temporal dispersion of 
recovery following the premature beat correspondingly 
increases (Spear ~ ~ 1973). Coincident with this 
increasing inhomogeneity of repolarization of the 
ventricle, repetitive extrasystoles, ventricular 
tachyarrhythmia and finally VF are el icfted. 
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Indeed, a strong cause-and-effect relationshfp 
between Increased temporal dispersion of refractoriness 
and Increased vulnerability to arrhythmogenesis, as 
judged by the VFT, has been suggested by the work of Han 
~ ~ (1966a), Han ,!tl. .al.... (1966b) and Spear ..eJ;. .a.1-
(1973). Ventricular fibrillatlon only occurs when the 
myocardium is grossly disparate in terms of recovery from 
excitation. The electrical stfmulus can provlde both an 
excitable stimulus (i.e. a premature beat) as well as a 
means of fostering reentry. 
There are at least three characterf stics of 
premature beats which contribute to the reentry process. 
The first is their relatively slow conduct i on velocity as 
compared to normal sinus beats. Secondly, premature 
beats tend to cause an increase in the normal temporal 
dispersion of refractoriness (Han and Moe, 1964). 
Thirdly, premature beats generally have longer vulnerable 
periods than do normal beats ( \>/egria et~ 1941). 
Surawicz ~ ~ (1967) reported that those premature 
beats preceding multiple extrasystoles and VF have 
significantly shorter effective refractory period (ERP's) 
than do single premature beats. In turn, single 
premature beats have shorter ERP's than do normal beats. 
This shortened ERP is, most probably, one reason for the 
prolonged vulnerable per i od duration of premature beats. 
In summary, deliver i ng a sin g le electrlc pulse to 
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the myocardium el I cits a premature extrasystole. As the 
stimulation current increases, the electrical recovery 
from the premature response becomes more asynchronous. 
At some critical stage this asynchrony reaches the point 
where multiple reentry is made possible and VF ensues. 
Many of the early workers in this field (i.e. prior 
to the 1gso's) did not pace the heart via a second 
stimulator. To be able to accurately place the 
stimulating pulse during the cardiac vulnerable period, 
many of these investigators triggered their shock (with 
an appropriate delay circuit) from the electrocardiogram 
R wave (e.g. Shumway !:.t, ~ 1957). However, more recent 
investigators have often artificially controlled heart 
rate 
have 
by supraventricular or ventricular pacing. Some 
even severed autonomic innervation to the heart and 
crushed the SA node in an attempt to block spontaneous 
activity or reflex autonomic activation~ Such pacing Ts 
necessary in the single pulse method using the dog, since 
in this preparation heart rate has been shown to be one 
determinant of the VFT (Han~~ 1966a). 
In developing the single pulse technique, numerous 
authors have demonstrated that certain technical aspects 
of the method could affect the resulting threshold. The 
first of these determinants of VFT were those proposed by 
Wiggers and Wegrla (1940b), and 1 isted previously. 
Shumway et .9.L_ (1957) then reported that VFT was less 
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when the stimulating electrodes were placed in the right 
ventricle as compared to similar measurements Jn the left 
ventrlcle. Van Tyn and Mac lean (1961) examined three 
other factors which they thought could affect the 
fibrillation threshold; namely interelectrode distance, 
time interval between stimuli and anatomic location of 
the electrode placement. Their findings indicated that 
an interelectrode distance of 2-4 mm yielded 
significantly higher VFT values, as well as being more 
variable, than similar determinations with an 
interelectrode distance of 10-35 mm. Based on further 
study, these investigators determined that this 
difference was due to short circuiting of the stimulating 
current through locally damaged tlssue. It was also 
shown, by these investigators, that stimuli delivered 10 
beats apart produced significantly higher ~FT's to 
than 
Van 
15 
stimuli placed three or four beats apart. Finally, 
Tyn and Mac lean demonstrated that VFT was higher at 
the base of the ventricles than at the apex. 
The single pulse technique mimlcs, to a certain 
extent, naturally occuring extrasystoles Jnltfated by an 
ectopic pacemaker. The current delivered to the 
myocardium during threshold determination is greater than 
that just necessary to develop a propagated impulse -
i.e. the excitability threshold. However, the increased 
current density is required to increase the Inhomogene i ty 
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of the ventricle to the point at which sustained 
arrhythmlas can develop. _ In those clinical sltuations 
where the R on - T phenomenon (that ls a premature 
systole occuring during the T wave of the prevlous beat) 
initiates arrhythmogenesis, the lncreased disparity in 
temporal recovery of excitability is generally caused 
either by increased sympathetfc tone and/or lschemlc 
coronary heart disease. 
Other advantages of the single shock technique are, 
more generally, advantages of the entire process of 
electrical fibrlllation threshold testing. For example, 
one advantage of the electrical fibrillation threshold is 
the fact that the effect of the stlmulation is readily 
reversible. Secondly, the procedure can be used to 
measure both increases and decreases in susceptibility to 
arrhythmogenesis. Thirdly, the method is capable of 
assessing vulnerability at relatively frequent time 
intervals. Fourthly, the quantitative nature of the 
threshold provides a means of developing dose-response 
phenomena when studying arrhythmic or antlarrhythmic 
agents. Finally, the technique is flexible enough to 
study the entire range of preparations from in sltu, 
cardiac preparations, which are physiologic in nature and 
as a result often quite complex, to isolated portions of 
the myocardium, which provide a somewhat less physiologic 
model, but accordingly provide a simpler preparation. 
When 
electrical 
relatTvely 
studying 
comparing the 
fibrillation 
single 
threshold 
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shock method to other 
techniques, it is 
time consuming and, as such, its use in 
rapidly changing processes rs often precluded. 
The reason for the time consuming nature of the method ts 
that the vulnerable period must be clearly defined so 
that the reported threshold Ts the minimal current value 
necessary to initiate arrhythmia. This problem can be 
extremely acute when the vulnerable period is very short. 
This difficulty is particularly relevent to this thesis 
since Lubbe and co-workers (1975) reported that isolated 
perfused rat heart had a mean vulnerable period of only 3 
msec. 
Another disadvantage of the single shock method is 
that the thresholds are somewhat higher than those 
measured using the trains-of-pulses method (Tamargo~ 
~ 1975). High intensity shocks, especially when 
applied in each cycle, are capable of injuring cardiac 
tissue. 
2) The alternating current method 
Hoff and Nahum (1934) were the first to use 
alternating current (60 Hz) to assess vulnerability to 
VF. In their study 110 volt A.C. shocks lasting longer 
than 0.5 seconds and appl led through bipolar 1 imb leads 
consistently caused VF in the cat. Administration of a 
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cholinerglc agonist (acetyl-beta-methyl choline chloride 
/ 
25 mg. s.c.) prevented the development of VF, but could 
not prevent atrial fibrillation. In addition, Hoff and 
Nahum reported that adrenalectomy combined with a 
bilateral removal of the stellate ganglia also protected 
the cat's heart from VF. Subcutaneous administration of 
adrenaline, however, again made the heart susceptible to 
fibrillation Induced by the 2-3 second train of A.C. 
pulses. 
Later, Wegria and Wiggers (1940b) examlned the 
methodology of A.C. induced arrhythmogenesis. Their work 
utilized direct stimulation of a small portion of the 
dog's eplcardlum with alternating current of much less 
voltage than that used by Hoff and Nahum. Trains of from 
o.s to 4 sine waves in duration (8.3 to 66.7 msec.) acted 
like brief D.C. shocks. That is, if applied during the 
vulnerable period and with sufficient strength, 
fibrillation ensued. Otherwise, that is if applied at 
some other portion of the cardiac cycle or at less than 
minimal strength, VF could not be el iclted. The unitary 
nature of this oscillating stimulus was explained by the 
investi gators as being due to the fact that all those 
cycles occurlng after an effective pulse would occur 
during the refractory period of that effective pulse and, 
as a result have no furt her arrhythmogenlc effect. 
Longer durations of A.C. stimulation (7- 9 cycles), 
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at currents below the threshold values of the shorter 
train lengths, were also shown to be Incapable of causfng 
the development of VF when begun at the inception of the 
vulnerable period. However, those longer tralns were 
able to cause fibrillation when begun later ln the cycle, 
vts. during early diastole. That reductlon in the 
threshold current for such trains appl Ted ln early 
dlastole was said to be caused by a lower excitability 
threshold at that time. Accordingly, a premature 
extrasystole could develop at that time, and subsequent 
cycles could eventually fall during the vulnerable period 
of that propagated extrasystole. Such an occurance was 
thought to cause a reduced fibrillation threshold, an 
assumption supported by Han .e.t aL... (1966) but not proved 
until 1967 (Sugimoto~ aL... ). 
Sugimoto and co-workers (1~67), in fact, restudied 
certain factors of the A.C. method in terms of their 
relationship to the measured threshold. A flve second 
A.C. stimulatlon yielded a threshold 30 times less than 
the threshold measured using a single, 10 msec. square 
wave pulse. Weak A.C. stimulatlon (i.e. 0.4 mamp.) had 
to be delivered for at least a period of 800-1000 msec. 
to initiate VF. Again, threshold decreased 
proportionally to the duration of the stimulation period. 
More specifically, as the stimulus duration increased, 
the number of extrasystoles increased, and threshold fell 
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exponentially with that tncrease in the number of 
extrasystoles. By showing that this correlation of a 
reduced threshold with successive extrasystoles could be 
seen regardless of by which method of electrical 
stimulation the extrasystoles were generated and the 
vulnerability tested (i.e. trains of rectangular pulses 
or 60 Hz sinusoidal alternating current), it was 
concluded that the occurance of the extrasystoles, in and 
of themselves, reduced the threshold. 
Use of the A.C. method has certain advantages over 
the single pulse method. Firstly the A.C. stimulus 
exactly mimics the electric shock delivered by 60 Hz. 
wall current. Leakage of very weak currents from 
improperly grounded electrical equipment may in i tlate VF 
in patients (Starmer ~ .s.l.a....r.. 1964). As a result, 
threshold testing using the A.C. method has definite 
practical significance. 
Secondly, the threshold measured ustng the A.C. 
method is far less than that measured using the single 
pulse technique. This characteristic minimizes the 
possibility of damaging the myocardium with large 
currents. 
There remains, however, practical difficulties in 
the use of sinusoidal alternating current to assess 
vulnerability. Primarily, because of the biphasic nature 
of the wave form, current measurement ls technically 
difficult. 
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Also it would seem to be necessary to 
initiate the pulse train each time at the same point of 
the sinusoidal wave; otherwise the variable initial pulse 
would presumedly alter the threshold. This requirement 
again presents technical constraints. 
3) The train of pulses method 
The most recently developed method of electrical 
fibrillation threshold testing has been the train of 
pulses method. Han (1969) was the first to use this 
technique of applying a gated train of monophasic, 
rectangular pulses to the heart to assess vulnerability. 
In that first use, the train was initiated just after the 
R wave of the cardiogram and was sustained just to the 
peak of the T wave. Each pulse was 2-4 msec in duration, 
and the pulses were delivered at a rate of 100 cycles per 
second. Current was 
fibrillation ensued; 
progressively increased until 
that current was then taken to be 
the fibrillation threshold. 
One Interesting result from this study was that the 
time lnterval between elicfted extrasystoles became 
progressively shorter at increasing stfmulatlon currents. 
As a result, it was possible to correlate the ventricular 
fibr'illation threshold (VFT) wi th a minimal "critical" 
coupling interval. This finding had practical 
applicability in that it was used in that same study as a 
measure of vulnerability. 
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Using trafns of increasing 
duratfon, but constant current, susceptJbil tty to VF was 
estimated by the duration of the train, the number of 
acceleratfng premature beats required to induce 
fibrlllation and the critical cycle length of the 
premature beat just preceding fibrJllation (i.e. the 
interval from the previous beat to that extrasystole just 
precedJng VF). 
Because of its ease of application and, most 
notably the rapidity with which VFT can be measured, the 
traJn of pulses method has found widespread use Jn the 
past seven years (Moore and Spear, 1975). However, the 
underlying assumption that only a single pulse within the 
train initiates arrhythmia, and correspondingly that 
other pulses wJthin the train have 1 Jttle or no effect on 
vulnerability does not seem val id. The study of Tamargo 
et ~ (1975) reveals that the train of pulses method 
yields a significantly lower VFT than does the single 
pulse technique. Obviously then, the train represents 
more than just many stimuli; only one of which initiating 
VF. 
More importantly, the threshold seen when using the 
train of pulses is highly dependent on the moment durlng 
the cycle at whlch the train is del lvered. A train 
initiated very early Jn diastole and terminating at that 
point in the vulnerable period when fibrfllation 
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threshold is at a minimum (i.e. the nadir of the VFT 
curve), yields the same threshold as that found scanning 
the vulnerable period with a single pulse. However, a 
train initiated just at the nadir and progressing through 
the peak of the T wave yields thresholds significantly 
higher than those measured using the single pulse 
(Verrier .e..t. ~ 1976). Weiss il aL.. (1973) found a 
similar increase in VFT when the train progressed past 
the vulnerable period nadir, and accordingly named thls 
portion of the cycle the protective zone. Trains 
delivered very early in the refractive period, but ending 
prior to the nadir, also yield VFT's greater than the 
single pulse. Conversely, trains initiated just prior to 
the nadir, but still progressing through the nadir and 
protective zone show thresholds slgnificantly less than 
the s i n g 1 e shock method; th a t i s , as Ta ma r go tl ~ 
(1975) demonstrated. In conclusion, thresholds assessed 
using the train of pulses technique is hiehly dependent 
on train placement in the cycle relative to the nadir of 
the VFT curve. 
Brady tl aL.. (1960) and later Vicenzi and West 
(1963) both demonstrated that trains of pulses were 
capable of causing the release of endogenous cardiac 
neurohormones, e~g. norepinephrine, and to a lesser 
extent, epinephrine. However, the Brady paper presents 
evidence suggesting that the single pulse is also capable 
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of releasing cardiac catecholamines. As a result, this 
phenomena is probably seen with all modes of electrical 
stimulation of the heart. Therefore the secondary effect 
which the catecholamines may play on vulnerabll ity would 
be seen, at least to some extent, with all modes of 
electrical flbrtllation threshold testing. 
Although not a train of pulses method, the 
sequential R on T technique developed by Thompson and 
Lown (1972) and separately by Gamble and Cohn (1972) was 
based on successive decrease in threshold with successive 
extrasystoles. In the technique utilized by Lawn's 
group, three monophasic rectangular pulses are delivered 
in close succession, each one being delivered just after 
the refractory period of the previous beat. This 
technique is thought to reduce the variables seen with 
the train of pulses technique, particularly tn relation 
to the dependence of the threshold on train placement 
within the cycle. 
Factors Known To Affect Vulnerability 
As long ago as 1859 it was demonstrated in 
laboratory preparations that altering the vulnerability 
of the heart to fibrillation was poss i ble CEinbrodt, 
1859). More recently, it has become accepted in the 
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clinic that certain agents, in particular 
antfarrhythmfcs, decrease vulnerabf 1 Tty to VF whereas 
other agents and disease states may make the heart more 
susceptible to ftbrillatlon. 
A list of agents and interventions which have been 
shown to affect vulnerabll ity would be qulte large. Many 
have been referred to prevlously in this review. As a 
result, the present discussion will be 1 imited to 1 isting 
some pertinant agents and then going into detail only ln 
those cases whlch have not been previously discussed and 
particularly warrant such discussion in terms of the 
focus of the present study. 
A partial 1 ist of drugs reported to have reduced 
cardiac vulnerabJl Tty to VF is presented ln table I. 
Most of these agents can be categorized into one of two 
broad groups. The first group would consist of drugs 
which directly stabilize cardiac membranes and therefore 
reduce automaticity. This group includes the classical 
~ntiarrhythmic agents such as procaine amide, 
dihydroquinidine and 1 idocaine. The other group are 
agents which cause a reduction in sympathetic tone to the 
heart. Within this latter group are direct acting beta 
adrenergic blocking agents, e.g. propranolol and 
practolol, agents which are thought to indirectly reduce 
catecholamine release (reserp ine, bretyl i um, perhaps 
edrophonium, methachol ine and isoprenal ine) and factors 
TABLE l 
Drugs Which Reduce Vulnerabil tty 
to Ventricular Fibrillation 
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DRUGS REFERENC:E(S) * 
Acetylstrophanthidtn (Intact nervous system) 
Aj ma 1 i ne 
Amtnophyll ine (following brief elevation 
in vulnerability) 
Antazol ine 
B rety 1 l um 
Clonidine 
Dibenamine 
Dihydroquinidine 
Diphenylhydantoin 
Edrophonium 
Epinephrine (following brief elevation 
in vulnerabil lty) 
Guanethidine 
Hydroxyzine 
I soprena 1 i ne 
LT doca i ne 
Methachol ine 
Morphine 
Noreplnephrine (following brief elevation 
i n v u 1 n e r a· b i 1 i t y ) 
Novacaine 
Ouabain 
Papaverine 
Phenylephrine 
Physostigmine 
Practol ol 
Procalne 
Procainamide 
Pronethalol 
Propranolol 
Qulnidine 
Reserpine 
1 
2 
3 
2 
4,5,6 
7 
8 
2 
2,9 
10 
8,11,12 
4 
2 
13 
2,6,14 
15 
16 
12 
17 
1 
8,11 
18 
19 
20 
17 
2,21 
4 
4,22 
8,11 
4 
* References are 1 isted by number in the appendix. 
which reduce sympathetic 
action (e.g. clonidine). 
Table I I provides 
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outflow as a result of CNS 
a partial list of physiologic 
interventions 
arrhythmia. 
the heart. 
which reduce vulnerability to ventricular 
All cause a reduction in sympathetic tone to 
Arrhythmias associated with coronary 
occlusion seem to be related to a variety of sequelae to 
ischemia. lschemic myocardium elicits neural and humeral 
responses which are pro arrhythmogenic. Sympathetic 
reflexes following coronary occlusion have been 
demonstrated by Mall iani .!tl, .£L... (1969). Attenuatfon of 
cardiac vulnerabll Tty assoc fated with ischemia is 
produced by beta adrenergic blocking agents. Humeral 
responses increase vulnerability during sudden 
reperfusion of the coronary circulation since it has been 
shown that beta blockade is ineffective in regucing 
reperfusion associated arrhythmias (Lown _g_t ~ 1977). 
lschemic and infarcted tissue also directly alters 
conduction velocity and causes disparity in refractory 
period duration within adjacent areas of myocardium. 
Such effects directly predispose the heart to arrhythmfa 
(see Vulnerability To Ventricular Fibrillation). 
Development of collateral circulation prevents these 
effects by 1 imiting the ischemic zone slze. 
Other factors reported to increase vulnerability to 
VF are 1 isted in Table I I I. One group of factors 
TABLE _11 
Physiologfc fnterventlons Which Reduce 
Vulnerab11 lty to Ventricular Fibril latlon 
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INTERVENTtON REFERENCE * 
Aortic Occlusion Induced Hypertension 
Reduction of Psychological Stress 
Right Stel late Gangl ion Ablation 
Collateral Coronary Artery Development 
Prior to coronary artery occlusion 
* References are listed by number in the appendix. 
18 
23 
24 
25 
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increase sympathetic activity to the heart. A second 
group causes direct cardiac toxfcity. A third group of 
factors increase vulnerability by unknown mechanlsms. 
Stress factors which predispose the heart to 
ventricular arrhythmia do so primarily by stimulating the 
sympathetic nervous system (reviewed by Raab, 1966). 
When stress is combined with other factors which increase 
sympathetic activity, e.g. myocardial ischemia, 
spontaneous ventricular arrhythmia ls often evident. 
This extreme elevation in vulnerability to arrhythmia 
represents an additive effect of the two factors 
stimulating the sympathetic nervous system. A pertinant 
example of this additive effect ls the demonstration that 
caffeine infusion further reduces VF threshold in dogs 
with coronary occlusions (Bel let~~ 1972). 
Caffeine - Its Relevent Pharmacology 
~ Chemistry, Source and Pharmacokinetics 
Caffeine, 1,3,7 trimethyl xanthine, is one of a 
group of pharmacologically active xanthines including 
theophylline and theobromine. All the methylated 
xanthines directly stimulate the central nervous system, 
cardiac and skelatal muscle as well as producing diuresis 
TABLE _11_1 
Interventions Whfch Increase 
Vulnerabil fty to Ventricular Fibrillation 
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INTERVENTIOfl MECHANISMS * REFERENCE (s)** 
Metabolic acidosis 
Anoxia 
Myocardial ischemia 
Abrupt coronary reperfusion 
Premature venticular beats 
Digltal ts (following propranolol 
A,C 
A,B,C 
A,B 
A,C 
A 
or denervatTon) A 
Epinephrine or norepinephrine 
(initially with infusion) 
I soprenal lne 
Aminophyll ine (during 20 minute 
infusion) 
Ca ff e f ne ( i . v.) 
Ouabain (in toxic doses) 
Quinidine (in toxic doses) 
Chloroform plus epinephrine 
Aconltlne 
Hypokael.emia o~ hypercalcemia 
Barf um chloride 
Sympathetic nerve stlmulatlon 
Electrical stimulation of 
posterior hypothalamus 
Caffeine injection to 
lateral ventricle 
Psychological stress 
* 
A 
A 
A,B I 
A,B 
A,B 
A 
A 
A 
A 
A 
B 
B 
B 
B 
26 
27 
28,29,30 
31 
32 
1 
12 
27 
3 
33 
34 
34 
35 
36 
37,38,3g 
40 
12 
40 
41 
42 
A. Direct acting cardlotoxins (including direct 
alteration of normal cardiac electrophysiology) 
B. Increase sympathetic tone to the periphery 
C. Unknown mechanism 
** References are 1 isted by number in the appendix. 
and smooth muscle 
alkaloids in this 
greatest effects on 
relaxation. Of 
class, caffeine 
the brain and 
peripheral autonomic nervous system. 
the 
tends 
the 
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three major 
to have the 
least on the 
These methyl xanthines are found as natural 
products of vartous exotic plants. Caffeine ts found tn 
coffee, a decoction of coffee bean (Coffea arabica). 
Tea, an infusion of tea leaves (Thea sinensis) also 
contains caffeine as well as theophyll ine. Both caffeine 
and theobromine are obtalned from cocoa, a product of 
Theobroma cacao seeds. Caffeine is also found in certain 
soft-drink sodas, particularly those ln the cola family 
(from the nuts of the Cola acuminata tree) (Ritchie, 
1975). 
The amount of active alkaloid per cup of beverage 
has been 
partly as 
given numerous values over the past Century, 
a result of differing measurement technTques 
and partly because of differences Tn definition, or lack 
the re of, of the term "cup". Recent 1 y Burg ( 19 7 5) 
reported that a cup (5 to 5.5 oz or 148-163 ml) of 
brewed, roasted and ground coffee contained from 64 to 
124 mg of caffeine. The average caffeine content of the 
eleven brands tested was 83 mg/cup. A compilation of 
1 iterature values from the past twenty five years 
provided an average value of 95 mg/cup (see Burg, 1975). 
Burg stated that instant coffee contained an average of 
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59 mg/cup whlle recent 1 lterature values suggested that 
there was 81 mg/cup. Decaffeinated coffee contained just 
3 mg/cup. Tea has been analyzed as having anywhere from 
28 (instant tea) to 42 mg/cup (bagged tea), but again a 
survey of recent 1 iterature values suggested much higher 
values; 45 mg/cup in fnstant ' tea and 65 mg/cup in leaf 
tea (data from Burg, 1975). These discrepencies Jn 
caffeine content seem to relate to the larger standard 
cup (i.e. 250 ml) used in many of the earlier studies 
(Wolman, 1955). Theophyll ine has been found in only 
small quantities in black leaf tea ( <0.3 mg/cup). Burg 
reported that tea has a theobromine content of 2.3 mg/cup 
whereas cocoa contained an average of 252 mg/cup of this 
methylated xanthfne. 
Following oral administration in man, caffelne is 
rapidly and essentially completely absorbed from the 
gastrointestinal tract (Sant' Ambrogfo _g_t ~ 1964). 
Peak blood levels following oral administration of the 
caffeine alkalofd were reached 30 minutes after 
ingestion. Caffeine sodium benzoate was absorbed more 
slowly from the gut. When taken by mouth, the peak 
caffeine level was seen 60 minutes following 
administration 
(i .v.) of the 
of the sodium benzoate salt. Injection 
same dose of caffeine produced the same 
peak plasma level and the same time course of metabolism 
as seen with oral administration of the salt (Axelrod and 
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Reichenthal, 1953). 
Caffefne is freely and rapidly distributed to 
various bodily tissues. The distribution of caffeine is 
directly related to the tissue water content - fndicating 
unimpeded diffusion (Axelrod and Reichenthal, 1953). The 
initial decrease in plasma levels due to distribution of 
the drug is rapid. Half 1 ife Jn plasma is approximately 
1.5 minutes (Sant' Ambrogio ~ ~ 1964). Caffeine 
passes rapidly into the brain. Subcellular distribution 
indicates that caffeine is not accumulated in sealed 
cytoplasmic compartments. Compartmentation in the 
nucleus, however, is found to a small degree (Galli and 
Spagnuolo, 1975). The liver concentrates caffeine to a 
slight extent in that the ratio of tissue water caffeine 
to plasma water caffeine is 1.11 (Axelrod and 
Reichenthal, 19S3). This concentration effect presumably 
indicates the site of biotransformation of the compound. 
In man, 99 per cent of ingested caffeine is 
biotransformed prior to excretion. The major products of 
biotransformation are 1-methyluric acid and 
1-methylxanthine. Excretion of these products are in 
relatively equal amounts (Ritchie, 1975). The half time 
of the biotransformation is approximately 3 to 3.5 hours 
(Axelrod and Reichenthal, 1953 and Sant' Ambrogio _g_t ~ 
1964). 
With the ingestion of eight cups of coffee (80 
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mg/cup) over a ten hour perfod, mean plasma caffeine 
levels were shown to rfse from 0.45 mg/1 to 4.1 mg/l. 
This daily accumulation of caffeine was estimated to be 
equfvalent to a therapeutic blood level of the drug (i.e. 
180 mg), however there was no day to day accumulation of 
caffeine as demonstrated by its disappearance by the 
following morning (Axelrod and Reichenthal, 1953) • 
.!L. Pharmacologic Activity 
1) Central nervous system 
From biblical times it has been known · that caffeine 
containing beverages, coffee in particular, stimulates 
the brain producing the feel Ing of wakefullness and 
preventing fatigue. This cortical activation is 
accompanied by activation of other levels of the central 
nervous system (CNS), including midbrafn, brainstem and 
spinal cord. Toxic manifestations of caffeine ingestion 
primarily include signs of CNS overstimulatfon including 
restlessness, excitation and insomnia with progression to 
delerium or convulsions at larger doses (Jokela and 
Varttainen, 1959). 
Beyond the behavioral effects there are other 1 Ines 
of evidence suggesting central nervous system actions of 
caffeine. The drug rapidly and easily passes into the 
brain. Nearly two thirds of that taken up by the CNS 
reaches the encephalon, 
cerebellum and 15% In 
Spagnuolo, 1975). 
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while 23% is found in the 
the brain stem (Galli and 
Peripherally administered caffeine ls known to 
cause neurochemical alterations In the CNS. Following 
caffeine lnjectlon brain norepinephrine (NE) is thought 
to be released from neuronal storage sites since there is 
a short 1 ived increase in the NE turnover rate (Berkowitz 
et ~ 1970; Waldeck, 1971 and Corrodi tl ~ 1972). 
lntraperitoneally injected caffeine (25-100 mg/kg) also 
caused a biphaslc alteration in dopamine (DA) turnover 
rates (Waldeck, 1971 and Carrodi tl ~ 1972). When 
Injected 30 minutes prior to testing with caffeine (100 
mg/kg i.p.), tritlated DA production from labeled 
tyrosine was doubled, indicating acceleration of DA 
turnover. However, when administered 2 hours prior to 
tritfated tyrosine, DA turnover was decreased (as 
measured 3 hours after the caffeine injection). Brain 
serotonin turnover rates are decreased with caffeine 
injection (Carrodi tl ~ 1972). 
Further results from the Waldeck (1971) and Carrodi 
tl ~ (1972) studies suggest that the primary action of 
caffeine, at presynaptic sites, is to release both NE and 
DA. This conclusion ls based on the following findings. 
Monoamine oxidase (MAO) Inhibition Increases the free 
cytoplasmic pool of catecholamines, which in turn reduces 
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tyrosine hydroxylase activity by a feedback mechanism. 
As a result of decreased catecholamine synthesis, MAO 
inhibition ls perceived to reduce turnover rates (Carlson 
g_t ~ 1960 and Neff and Costa, 1966). Caffeine, 
however, reverses blockade of tyrosine hydroxylase 
related to MAO inhibition. 
Caffeine Induced release of NE and DA to the 
synapse would reduce the effect of MAO inhibition on 
catecholamine concentration in presynaptic cytosol. 
Released catecholamine may also be degraded by 
catechol-o-methyl transferase, found at postsynaptic 
sites. Furthermore, since caffeine significantly 
accelerates the reduction of NE levels in mouse brain 
following dopamine-beta-hydroxylase Inhibition, it must 
be assumed that caffeine directly releases catecholamine. 
The increased turnover rate following caffeine would 
therefore be evident regardless of any secondary 
inhibition of tyrosine hydroxylase. 
There is also evidence to suggest that c~ffeine 
augments 
action. 
post synaptic 
Waldeck (1973) 
dopaminergic and noradrenergic 
demonstrated that concommitant 
caffeine injection augmented direct act i ng dopaminergic 
and noradrenerg ic agonlsts CET 495 and clonidine, 
respectively) in their ability to reverse reserpine 
reduction in locomotor activlty. This effect was st i ll 
seen after tyrosine hydroxylase inhibition, thus further 
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ruling out presynaptfc effects. Since pimozide (a 
dopaminergic antagonist) blocks this caffeine related 
increase in locomotor activity, it is suggested that post 
synaptic dopamtnergic augmentation is the crucial factor 
related to this caffeine effect. Taking all these 
findings into consideration plus the fact that caffeine 
pretreatment 
(Carrodi ~ 
reduces amphetamine 
~ 1972), it seems 
induced rotation 
that caffeine acts 
similarly 
effects. 
to 
That 
amphetamine, at 
is, caffeine 
least in terms 
causes release 
catecholamines and stimulates postsynaptic 
catecholaminergic receptors. 
2) Peripheral nervous system 
of CNS 
of 
Caffeine administration, whether it be via the oral 
route in man, the intraperitoneal route in the rat or the 
intravenous route in the dog, causes a release of 
catecholamines from neural and chromaffin tissue of the 
adrenal medulla. De Schaepdryver (1959) first 
demonstrated an increased secretion of epinephrine (EPI) 
and NE from the adrenal glands following intravenous 
caffeine infusion in the dog. Peach (1972) and Poisner 
(1973) conflrmed and extended these findings. Levi 
(1967) then reported that three cups of coffee increased 
the urinary excretion of adrenaline by man. A similar 
investigation by Bellet and coworkers (1969) demonstrated 
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an increase in total urinary catecholamines (45 %), 
norepinephrine (32 %) and epinephrine (77 %) fol lowing 
the consumption of two cups of tnstant coffee. 
The effect of caffeine on cardiac catecholamine 
content and turnover has been studied by Berkowitz and 
Spector (1971). Caffetne injectlon (50 mg/kg, i.p.) 
caused no reduction in cardiac catecholamine content tn 
the rat or gutnea pig. Following blockade of tyrosine 
hydroxylase with alpha methyl paratyrosine (150 mg/kg), 
cardiac levels of NE and EPI were reduced. Caffeine 
administration following the alpha methyl paratyrosine 
injection, was associated with a signlficant increase in 
cardiac EPI content, but did not reverse the inhibitor 
induced reduction in NE levels. Since the increase in 
cardiac catecholamine content was not seen following 
adrenalectomy, the authors concluded that caffetne 
released adrenal epinephrine into the circulation. With 
depletion of cardiac NE stores, the circulating EPI would 
then be taken up by the heart. 
Berkowitz and Spector (1971) failed to demonstrate 
caffeine-induced release of the catecholamines from the 
heart. However, in the study by Westphall and Flem i ng 
(1968) reserpine pretreatment was shown to re duce 
aminophylline associated tachycardia. Furthermore, 
propranolot administration also reduced the chronotropic 
response of this methylxanthine. These results support 
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activity. 
Although caffeine is known to cause the release of 
catecholamines, it is 
less significant than 
heart. This conclusfon 
now evident that this action Is 
caffeine's direct effect on the 
ls based on the fact that the 
xanthines have slightly dlfferent effects on the 
myocardium than do the catecholamines. Catecholamines 
accelerate tenson development in papillary muscle, 
whereas methylxanthines demonstrate an increase Jn 
tension which develops slower than normal (Marcus .tl ~ 
1972). In contrast to catecholamine action caffelne 
prolongs action potential duration. Finally, caffeine 
increases contractile force in isolated guinea pig atria 
pretreated with reserpine (de Gubareff and Sleator, 
1965). 
The supra-additive augmentat i on of beta agonist 
inotropism (Rall and West, 1963) suggests that caffeine 
may exert part of its cardiovascular effect at some site 
other than the post synaptic catecholamine receptor. 
Possible molecular mechanisms of this activity will be 
presented in subsection C of this discussion of 
caffeine's pharmacology. 
In 5 normal patients, coffee consumptfon has been 
shown to produce cardiac effects which are very much in 
accord with the action of caffeine described above. 
Caffeine containing instant coffee (158 mg/6 oz cup) was 
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consumed 20 minutes prior to cardiac catheterlzation and 
hemodynamrc assessment. A summary of the results 
demonstrated a 50% increase in left ventricular end 
diastol le pressure (from 4 to 6 mm Hg), an increase in 
left ventricular work (by 49 %), very slight sinus 
tachycardia, 43% increase in cardtac index and a 17% 
increase in cardiac oxygen consumption. No premature 
ventricular contractions were seen (Gould .e..t ~ 1973). 
4) Effects on ventricular vulnerability 
There are at least 5 experimental studies which 
have examined the effect of methylxanthines on 
vulnerability to fibrillation and subsequent death. A 
chronological 
resu 1 ts. In 
suscept i bfl ity 
incidence of 
review of those studies yfeld conflicting 
most, the methylxanthines increase the 
to arrhythmogenesis, however, In one the 
mortality with left circumflex coronary 
artery occlusion was reduced following methylxanthine 
administration (Le Roy !!,t. ~ 1942). Since these papers 
so directly relate to the present study, they will be 
discussed individually. 
Dikshit (1934) 
caffeine citrate (15 
demonstrated that smal l amounts of 
mg) could produce cardiac 
arrhythmias 
ventricle of 
when injected into the lateral cerebral 
cats. The arrhythmia, which was seemingly 
ventricular in origin was associated with a marked rise 
in blood pressure. 
barbitone (2S mg) 
arrhythmia. 
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Furthermore, the injection of sodium 
prevented the caffelne related 
Even prior to the Dikshit study it was demonstrated 
by Beattie ~ .aL. (1930) that i ntravenous caffeine 
administration (3S-4S mg/kg) could produce extrasystoles 
in decebrate cats. This effect was thought to be due to 
a direct effect of caffeine on the heart, since section 
of the cardiac nerves and adrenalectomy did not prevent 
caffeine's arrhythmogenic action. Conversely, Dikshit's 
finding that 10-12 mg/kg caffeine would produce 
arrhythmla when injected intaventricularly suggests that 
the drug increases susceptibility to arrhyt hmia by actin g 
within the CNS. 
The effect of aminophyll ine was studied on the 
pathological course of left circumflex coronary artery 
ligation (Gold ~ ~ 1937). Daily treatment with 
aminophyll ine (2S mg/kg, i.m.) for periods of three weeks 
following 1 i gation caused no alteration in the size of 
the subsequent infarct. Incidence of ventricular 
tachycardia was noticeably increased, however, in the 
aminophyll ine treated cats (47 % ~ g %). Amlnophyll ine 
was also shown to lower the i rritabi l lty t h reshold in 
papillary muscle (Greiner and Garb, 1 9SO). 
The study by Le Roy ~ .aL. (1 942) suggests that 
aminophylline reduces sudden death incidence in dogs 
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following left circumflex coronary occlusion. The 
protective effect was increased with more frequent 
administrations of the drug (i.e. 200-300 mg/day, p.o. 
for several days prior to testing and 120-240 mg, 1.m. 
before and after occlusion). The protective effect of 
aminophyll ine was also shown to be additive to the 
effects of atropine. The proposed mechanism of action 
was related to the ability of these agents to prevent 
coronary vasoconstriction and facilitate dilation of 
collateral coronary vessels. 
Two recent studies have examined the effects of 
caffeine and aminophyll ine on VF thresholds in the dog. 
Aminophyll ine reduced threshold for almost all of the 20 
minutes of infuson (Horowitz et ~ 1975). Thls 
reduction in VFT (30) was attenuated and reversed with 
continued amlnophyll Tne infusion. After the drug 
administration, threshold was elevated to 120% of control 
values. This biphasic alteration in threshold resembles 
the effect of intravenously administered epinephrine and 
norepinephrine (Han g.t. ~ 1964). The similarity of 
effects may suggest a similar pharmacologic mechanism. 
Presumably aminophyll ine causes a release of adrenal and 
cardiac catecholamines and/or directly stimulates cardiac 
catecholamine receptors (see subsections 2 and 3 above). 
Bellet et .9.1...s. (1972) demonstrated that caffeine sodium 
benzoate infusion (25 mg/kg; equivalent to 12.5 mg/kg of 
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caffeine base) reduced VFT by 15, 32, 29 and 20 per cent, 
when tested 15, 30, 45 and 60 minutes following drug 
administration. There was no subsequent elevation in VFT 
over control values as was seen with aminophyll Tne. The 
reduction in threshold was blocked by pretreatment with 
either propranolol (0.2 mg/kg) or practolol (0.6 mg/kg), 
again supporting the thesis of beta adrenergic mediation 
of the increase in ventricular vulnerability associated 
with xanthine infusion • . Caffefne was also shown to 
reduce VFT (by 23 %) in dogs tested four days after 
coronary artery 1 igation - a procedure which, in itself, 
reduced threshold by 20 per cent. 
£..t.. Molecular Mechanisms of Action 
Caffefne is known to alter three molecular 
pathways. These effects may mediate the pharmacologic 
activity of the drug as discussed above. the evidence to 
date, however, does not warrant ruling out other 
potential molecular mechanisms. Furthermore the effect 
of caffeine on each of these pathways is not necessarily 
mutually exclusive, i.e. altering one pathway may 
directly or indirectly alter a second effect of the drug. 
Caffeine inhibits cyclic nucleotide 
phosphodiesterase the enzyme which metabolizes the 
physiologically active cyclic 3'5' adenosine 
monophosphate Cc AMP) (Butcher and Sutherland, 1962). 
page 58 
The elevation of Intracellular c AMP levels following 
phosphodiesterase Jnhibltion have been correlated with 
the positive inotropic effects of the methylxanthines 
(Kukovetz and Poch, 1975). Phosphodi~sterase inhibition 
by the methylxanthines also potentiate the cardiac 
inotropic effects of epinephrine, histamine and glucagon 
all of which stimulate the synthetic enzyme, adenyl 
cyclase (Rall and West, 1963 and Mc Neill and Muschek, 
1972). Caffeine induced elevatlon in intracellular c AMP 
levels may be associated with an increase in 
susceptibility to arrhythmia according to the hypothesis 
of Podzuwelt _g_t ~ (1976). 
Caffeine Ts also known to increase transmembrane 
calcium flux and reduce sarcoplasmic reticulum uptake of 
calcium. The 
effects are 
electrophysiological consequence of these 
prolong the plateau phase of the action 
end result is also produced by 
to 
This potential. 
catecholamines, agaln suggesting similar actlvity of the 
two groups of drugs. 
There are two significant differences between 
caffeine and catecholamine effects, however, which 
suggest different molecular mechanisms. Firstly, 
caffeine prolongs the active contractile state of 
myocardial muscle, whereas catecholamlnes shorten 
contractlon by accelerating 
caffeine inhibits adenoslne 
relaxation. Secondly, 
effects on the myocardium. 
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The catecholamines do not produce this inhibition. 
Caffeine inhibition of adenosine's effects ls a 
third molecular mechanism by which it may act. Adenosine 
shortens action potential duration, reduces contractile 
force, slows heart rate and causes coronary vasodllation 
(Chiba ~ .aL.....c. 1973 and Thorp and Cobbin, 1967). The 
effects of adenosine and other purines have been 
suggested to be related to stlmulatlon of a 'purnerglc 
receptor' (see review by Burnstock, 1972). Caffeine may 
be a purinergic receptor antagonist • 
.IL. Caffeine Consumption, Tolerance and Therapeutic Use 
Consumption of caffeine ln coffee and tea makes 
this compound one of the most widely used drugs in the 
world. Treating rats with forced consumption of high 
doses of caffeine for two weeks led to subsequent 
preferential consumption of the drug when the rats given 
the choice of drinking caffeine solution or water 
(Vitello and Woods, 1975). These facts suggest that 
caffeine has some positively reinforcing property whJch 
makes it habit forming. 
Tolerance among coffee drinkers, develops to 
caffeine's diuretic, psychic and sleep disturbing 
actions. Caffeine significantly reduces heart rate when 
ingested by non coffee drinkers, but produces no 
consistent bradycardia in subjects wh o hab i tually consume 
caffenated beverages (Colton _g__t .E...L...c.. 1968). 
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Thus 
tolerance also develops to bradycardia with chronic 
coffee consumption. 
The most important therapeutic use of caffeine is 
related to its cortical stlmulation. The daily cup of 
coffee is often used to allay fatigue and drowsiness. 
Occasionally, caffeine sodium benzoate may be injected 
(0.5 to 1 gm) in the treatment of poisoning by central 
nervous system depressants. Caffeine is more often used, 
generally in combination with an ergot alkalold, in the 
treatment of migraine headache. The analgesic effects in 
such cases are thought to be due to a direct cerebral 
vasoconstrictor action of the combination. Ordinary 
headaches are often rel leved by combinatlons of caffeine 
with an analgesic. Conversely, it has been reported that 
some habitual c~ffee drinkers exhibit headaches following 
withdrawal of caffeine (Rltchie, 1975). 
Other methyl xanth ines, aminophyl line in 
particular, are often effective In reducing the symptoms 
of bronchial asthma. Based on their rapid 
bronchodilating activity, they are widely used in many 
instances of bronchoconstriction. Aminophyll ine is also 
occasionally used as a direct cardiac stimulant in acute 
episodes of congestive heart failure~ Finally the 
xanthines cause diuresis, however they have received 
relatively 1 imited use as diuretics since they are less 
effective than other agents. 
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METHODS 
Experimental Design and General Methods 
A. Basic Design .Qf. Experiments 
Groups of 6 rats were injected, per os, with 
caffeine (10 mg/kg, 30 mg/kg or 90 mg/kg) or with water 
just prior to ventricular tachycardia threshold (VTT) 
determination. In the . acute study, naive animals were 
injected once with the appropriate solution immediately 
prior to urethan anestesia and ventricular vulnerability 
testing. Subacute studies examined the effect of daily 
oral administration of either caffeine solution or water 
for periods of 2 or 4 weeks prior to study. Finally, 
continuous treatment for 8 or 10 weeks prior to testing 
constituted subchronic study of caffeine's effect on VTT. 
In the subacute and subchronic studies, in all but one 
group, each animal was treated just prior to VTT testing 
with the same solution (either caffeine or water) he had 
previously been administered. This acute oral injection 
immediately preceding vulnerability testing was labelled 
the "challenge dose". Using this procedure, the 
alteratton of the acute drug effect by previous chronic 
drug administration could be examined. However, in one 
group of rats treated for 10 weeks wtth 90 mg/kg 
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caffeine, water was injected just prior to threshold 
testing, to differentiate the effect of continuous daily 
injectlons from the acute drug effect. 
In part I I of the research, the effect of chronic 
caffeine treatment on the subsequent sensitivity of the 
rat heart 
tested. 
to 
Rats 
isoproterenol 
were maintained 
induced tachycardia was 
on a daily regimen of 
either caffeine (90 mg/kg/day) or water for 10 weeks. 
Studies of dose response curves of lsoproterenol on heart 
rate elevation were then performed. 
lL. Subjects, Animal Care and .QL..Y.,g, Treatment 
Albino, male, outbred rats weighing 150-175 gms 
were purchased from Charles River Breeding Labs and 
served as subjects in all experiments. Upon arrival at 
the Department of Pharmacology, the rats were either 
housed in colony cages (roughly twenty animals per cage) 
or separated into groups of 6 and housed in group cages. 
All animals were fed Agway Rat Chow and gJven tap water 
ad 1 lb. All subjects were housed in the same room 
throughout the course of the experiments with the light 
automatically set to provide a 12 hour light, 12 hour 
dark cycle. The animal quarters were maintained at 72 
degrees fahrenheit. The experiments were carried out 
over the period of July, 1975 to March, 1976. 
Two to three days after their arrival at the lab, 
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those animals seperated into cages of 6 per cage were 
arbitrarily chosen to receive one of the various drug 
treatments as indicated above and were so labelled. All 
animals in a given cage therefore received the same 
treatment. The rats were taken, as a group of 6, from 
their home cage and then individually weighed. While 
each rat was being weighed, his ca gemates would remain in 
the small plastic rectangular cage layered with absorbant 
used to transport the animals. All such handling of the 
subjects occurred in the late afternoon and early evening 
(4 p.m. to 8 p.m.). That choice of time was made to 
parallel the normal waking period of the nocturnal rat. 
After several such days of bein g handled and 
weighed, the rats were ready to be initiated on drug 
therapy. Each afternoon, pure caffeine base (chemical 
grade purchased from Matheson, Coleman an d Bell) was 
weighed on a Mettler analytical balance + 1 mg ) and 
then transferred to a 25 or 50 mg volumetric flask. The 
volumetric flask was then filled approximately two thirds 
full with distilled water and the solution was heated to 
40 degrees C, to allow the crystal to dissol ve. More 
distilled water was added to the flas k so t hat a final 
concentration of 45 mg /ml was attained. Necessary 
dilutions (to 5 and 15 mg/ ml) were subseq uently made from 
this stock solution. All solutions were transferred to 
conical flas ks and kept warm (30-35 de g rees centi g rade) 
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to prevent precipitation of the base. A separate 
Erlenmyer flask was fllled with distilled water, warmed 
and was used for injection of control animals. 
Initiation of drug administratfons to each group 
was scheduled such that the ftnal VTT testing for all 
groups 
period. 
given 
could be accomplished within an eight to ten week 
Schedules were also designed such that on a 
day, 4 rats were completed with their daily 
treatments and were tested for ventricular vulnerability 
to tachyarrhythmia. Pairs of water treated and caffeine 
(90 mg/kg) treated rats or pairs of rats treated with 30 
mg/kg or 10 mg/kg caffeine were studied together on a 
single day. 
Caffeine solution or water was injected, per os, in 
a volume of 2 ml/kg body weight. Curved stainless steel 
feeding tubes attached to 1 or 2.5 ml plastlc disposable 
syringes were used to Inject the solutions. A separate 
syringe and feeding tube was used for each dose (i.e. 
water, 10, 30, or 90 mg/kg). 
Each afternoon, all rats receiving caffelne were 
injected prior to those groups receiving water 
injections. However, the order in which the caffeine 
treated groups (and their water treated counterparts) 
were injected was rotated such that no group would be 
injected either first or last on consecutive days. 
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Ventricular Tachycardia Threshold Measurement 
A.t.. Sureical Procedure 
On the day of threshold measurement, each rat was 
taken from his cage, weighed and injected (p.o.) efther 
with the test solution which had previously been 
adminfstered or with water (see Basic Design of 
Experiments). If 4 rats (2 caffeine and 2 water treated) 
were to be tested that day, the order of testing would be 
varied in one of the following ways: 
water-caffeine-water-caffeine, 
caffeine-water-caffeine-water, caffeine-water 
-water-caffeine or water-caffeine-caffeine-water. A 
similar sequence would be followed if 2 rats treated with 
30 mg/kg caffeine and 2 rats treated with 10 mg/kg 
caffeine were tested on a sTngle day. 
Wf thin ten minutes of oral injection the rat was 
anesthetized with urethan (1300 mg/kg, i.p. in a 20% w/v 
solution). A surface lead I I electrocardiogram was 
recorded on a Grass Model 7 Polygraph and displayed on a 
Tektronix model 5103 N oscilloscope. Tracheotomy was 
then performed and positive pressure respiration 
instituted using a Narco V-100 Kg respirator. Bilateral 
thoracotomy at the fourth and fifth lntercostal space 
followed, with removal of the fourth rib bilaterally. 
The pericardium was incised, the heart exposed and the 
page 66 
lungs retracted. Room temperature normal saline (0.9% Na 
Cl) was dripped directly onto the epicardium at a rate of 
40-60 drops/minute throughout the experiment. 
Bipolar silver-silver chloride electrodes were then 
placed on the right atrial appendage to provlde right 
atrial pacing. These electrodes were 0.025 Inches in 
diameter and were plated prior to use by placing several 
pure silver electrodes In a 5% Na Cl solution and passing 
3 volts of cathodal D.C. current through them. The anode 
was a single silver electrode also placed In the beaker 
of salt water (Sidowski, 1966). Following the plating of 
these electrodes, they were soldered to electrically 
shielded teflon wires and coated with epoxyl ite for 
insulation. Just the tips of the electrodes were sanded 
so that electrode surface area could be estimated to be 
0.0032 square centimeters. They were pressed a gainst the 
myocardium so that there was no appreciable movement 
about the epicardial surface. However, the pressure was 
not enough to displace the entire heart. lnterelectrode 
distance was approximately 2 mm. Bipolar platinum wire 
electrodes (MS 303; Plastic Products Co., Roanoke, 
Virginia) were similarly placed on the right ventricular 
epicardlum approximately midway between the apex and the 
base of the ventricle. These electrodes, through which 
VTT test pulses were del lvered, were placed on the 
epicardial surface with an interelectrode distance of 2-4 
page 67 
mm. Prior to use, the electrodes had 1-2 mm of 
insulation removed from there tips. Electrode diameter, 
without insulation (as reported by the manufacturer) was 
0.010 inches. Stimulation surface area was estimated to 
be 0.0005 square centimeters. 
~Equipment Design 
Ventricular tachycardia threshold was measured by 
del iverlng a gated train of constant current monophasic 
rectangular impulses to the right ventricular epicardium 
during the vulnerable period of the cardiac cycle 
(modified from Han, 1969). Figure 1 provides a block 
diagram illustrating the electrical components for VTT 
testing. Right atrial pacing was instftuted using a 
Grass S 9 stimulator. The RF isolated output from the 
pacing stimulator was connected to a custom built, 
semiautomatic shut off device, then to a constant voltage 
to constant current converter and current measuring 
junction box. The output from the junction box then 
paced the right atrium through the bipolar silver-silver 
ch 1 o rf de e 1 e c t rode s p 1 aced on t he a n i ma 1 1 s r i g h t a t r i um • 
The test pulses of the t ra 1 n we re generated by a 
Grass SD 9 stimulator which was ultimately triggered from 
the pacer 'synch out' jacks (Figure 2) • Because of the 
desi gn of the SD 9 t tr lg in I system, however, it was 
necessary to maintain a constant positive pulse of at 
- ------------- - -
PACER 
Trig Volt 
Out out 
AUTO SHUTOFF 
DEVICE 
TRAIN 
DURATION 
REGULATOR 
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OSCILLOSCOPE 
EKG 
TEST PULSE 
GENERATOR 
Trig Volt L--------~ll--\-~------\-+-------~ in out 
Figure 1. Block Diagram of Electrical Components Used in 
VTT Testing 
PACER - Grass S 9 Stimulator 
AUTO SHUTOFF DEVlr.E - Semiautomatic Shut Off Device 
(diagrammed in Figure 4) 
CMD Constant Current Converting and Current 
Measuring Junction Boxes (diagrammed in Figure 3) 
TRAIN DURATION REGULATOR - Narco Physiograph SI - 10 
Stimulator 
AMPLIFIER - Tektronix Differential Ampl lfier, Model 
5 A21 N 
OSCILLOSCOPE - Tektronix Model 5103 N. 
HAND HELD 
S\-JI TCll 1------. 
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Figure 2, Wiri ng Diagram of Electrical Components Used in 
VTT Testing 
The design is discussed in the text. 
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1 ea s t 1 O v o 1 t s a t i t s 1 mod i n ' i n p u t f o r a s 1 on g a s the 
train of pulses was to last. A Narco Physlograph SI - 10 
stimulator was therefore used to generate such a positlve 
monophasic pulse. Its duration was equal to the required 
train length. The SI 10 stimulator was, in turn, 
triggered by the pacer synch out pulse, which was 
amplified by a Narco Physiograph Model 7070 amlplfier to 
meet the input requirements of the SI - 10 stimulator. 
With each pacing pulse, a train would be generated 
by th~ Grass SD 9 stimulator. However, Its output to the 
rat's right ventricle was short circuited to ground by a 
normally closed hand-held switch ( #2 )(see Figure 3). 
As with the pacing pulse, the test train was converted 
from a constant voltage to a constant current source 
using a 1000 ohm series resistance (Shumway~~ 
195 7). Current was measured by determining the voltage 
drop across a precision 10 ohm resistance (Figure 3). A 
Tektronix Differential Amplifier (Model 5 A21 N) 
quantffied the voltage drop of both the pacing and tes~ 
train output and displayed them on one beam of a 
Tektronix Dual Beam Storage Oscilloscope (Model 5103 N). 
A simultaneously recorded electrocardiogram was displayed 
on the second trace of the oscilloscope. 
0 e 1 l v e r i n g the test t r a i n to the an i ma 1 1 s he a rt by 
depression the hand held switch ( #2 Jn Figure 3) was 
only performed just after activation of the semiautomatic 
Grass S9 
+ 
Grass SD 9 
+ 
Right Atrium 
Ag-AgCl Electrodes 
Junction Box 
Right Ventricle 
Pt Electrode 
Junction Box 
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Tektronix 
Differential 
Amplifier 
SA 21 N 
Figure 3. Wiring Diagram of Constant Current Converting 
and Current Measuring Junction Boxes 
Current is measured by determining voltage drop across a 
10 ohm resistor. Constant voltage source is converted to 
constant current source by passing current through a lQOO 
ohm resistance. Switch at right ventricular output ls 
Hand Held Switch #2. 
Narco 
SI-10 * 
Trig in 
Nat co 
7070 AMP 
Aux in 
Channel 
Relay 114 
-0~ Pacer 
Trig 
out 
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Relay 112 
0 
Q-A 
o~ 
."a ~Pacer 
0 -A ,.....,,.t------------..J 0 ...---i:l output 
Atrial CME> 
D D 
Monitor **--------
Grass 
S4 
SYNCH 
IN 
24 V.D.C. 
Relay l!l Relay 1!3 
0 
-A Grass SD 9 
--0 --V _ I Trig 
~Q--J out 
+ --0 --A Q --A ~Grass ~v--0~-..1.~~~~~~~~~---------0-~----oo-tu-tp_!_~__J 
Grass polygraph 
Hand held switch #1 
Figure 4. Wiring Diagram of Semiautomatic Shut Off 
Device 
All relays are 24 volt D.C. electromechanical Type 
100. Contacts are double pole, double throw. 
(Milwaukee Relays Inc.) 
* Narco SI - 10 output to Grass SD 9 "Mod tn". The 
Grass SD 9 stimulator generates trains of pulses 
only during that period when the SI - 10 maintains 
a constant 40 volt pulse at the "Mod In" jack. 
** 50 microsecond, 90 volt pulse from the 
Physiograph Channel Monitor. 
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shut off device (Figures 1,2 and 4). Activation was 
initiated by depressing hand held switch #1. The next 
pacing pulse and test train was then delivered to the 
rat. Simultaneously, the pacer trig out pulse operated 
an electromechanical relay ( #3 ) via a fourth stimulator 
(Grass S4). 
Output from the Grass S4, "shut off" stimulator was 
delayed 140 msec after triggering, to allow the pulse 
train to the ventricle to be completed. It then 
del Tvered a 1 second, 70 volt pulse to operate relay #3, 
which, in turn, caused a 24 volt (D.C.) power supply to 
activate relay #2. Operation of relay #2 shorted future 
pacing pulses to ground. Release of hand-held swltch #1 
allowed pacing to be reinstituted. The sem iautomatlc 
shut-off device was thus desi gned to prevent any 
subsequent pacing pulses from poss i bly terminating 
tachyarrhythmia initiated by the test train. 
La_ Sti mulation Protocol 
Because the rat heart spontaneously beats at 
230-240 beats per minute (BPM) under u rethan anesthesia 
and open chest conditions, pacing was maintained at 
250-300 BPM. The pacing pulse was a 3 msec, monophasic 
rectan gular pulse usually 0.5 marnps i n stren gth. 
Following 6-10 paced beats, the test train was delivered 
to the right ventricle by depress i ng hand held switches 
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#l and #2 In rapid succession. 
The pulse train consisted of 2 msec, monophasrc 
rectangular pulses delivered at a frequency of 70 Hz. It 
was delayed 10 msec after the pacing pulse and continued 
for 90 msec. Thus, 6 pulses were delivered during the 
train. In relation to the electrocardiogram, the train 
was initiated just after the P wave and term?nated just 
prior to the T wave (Figure 5). This placement assured 
that the train intersected the vulnerable period of the 
cardiac cycle, but did not encroach upon the protective 
zone found just after the vulnerable period. 
Initially, the train was set at 2 mamp. If no 
sustained ventricular tachyarrhythmia developed at this 
current strength, pacine was reinstituted. Test current 
was increased by 2 mamp and following 6-10 paced beats, 
the train was again delivered to the ventricular 
epicardium. Sustained ventricular tachyarrhythmia was 
defined electrocardiographically, by a substantial 
reduction in mean arterial blood pressure, and by visual 
identification of a fibr?llatory quiverin g of t he 
ventricles. The arrhythmia had to be sustalned for two 
to three seconds (Figure 6). The ventricular tachycardia 
threshold was the minimal current which elicited 
sustained ventricular tachycardia. The VTT was measured 
between 40 and 60 minutes followi ng oral injection of 
test solution and subsequent urethan inject i on. 
rrrrrr 
i11HJ 0 
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Figure S. Localization of Test Train Within 
Cycle 
r I 
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The upper trace in each pair is the lead II 
electrocardiogram. The lower trace is a moniror of 
the output of the SD 9 Test Pulse Generator. The 
pulse is only delivered to the rat following the 
third paced beat. Train characteristics are 
described in the text. It is delayed 10 msec after 
the pacing pulse and ends well before the T wave. 
In the lower pair of traces current was Increased to 
12 mamps and VT was produced. Current in the top 
trace was 6 mamp. 
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figure 6. Card{ographfc and Hemodynamtc Documentation of 
VT 
The rhythm~c ventrtcular complexes of rapid rate 
and the fall t-n mean arterlal blood pressure from 
90 to 35 mm Hg ts charactertsttc of VT. The VT 
threshold was the min rmum current wh i'ch generated 
this cardtographic ,pattern, sustained for a 
mtnimum of 2 seconds: 
The middle trace indicates time (in seconds). 
Effect of Chronic Caffetne Treatment 
on Cardiac Sensitivity to lsoproterenol 
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A group of chronic caffeine treated rats were 
tested with increasing doses of isoproterenol (lsuprel R; 
Winthrop Labs) to determine whether there was any 
difference in the chrontropic effect of this drug in 
caffeine treated rats as compared to water treated 
controls. Daily oral caffeine and \'iater treatment was 
instituted in 2 seperate groups of rats for ten weeks as 
previously described. No acute drug treatment was given 
on the test day. 
The rats were anesthetized with sodium 
pentobarbital (50 
electrocardiogram 
mg/kg, i.p.). A surface lead II 
was then recorded for measuring heart 
rate. Following cannulation of the external jugular vein 
for the injection of drug, a bilateral cervical vagotomy 
was performed. lsuprel R was diluted with distilled 
water to concentrations of 2, 5, 20, 60 and 200 
micrograms per 
isoproterenol 
foil so that 
millili'ter. The vials containing the 
were air tight and covered with aluminum 
oxidation of the catechol would be 
minimized. The drug was infused at increasing doses with 
10 minute intervals between each drug administration. 
Following intravenous injection of 0.5 ml/kg of 
lsoproterenol, the catheter was flushed with 0.1 ml of 
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sal lne. Thus, the doses administered were 1, 3, 10, 30 
and 100 micrograms per kilogram of body weight. Peak 
heart rate elevation was recorded following each dose of 
isoproterenol. 
Statistical Methods 
Unless otherwise noted, all data is presented as 
mean + standard error of the mean CSEM). Statistical 
difference between two groups of rats in a given 
experiment was analyzed by applying the Student's t test 
for unpaired data (two tailed). An 01 ivettl Programma 
101 desk computer was used to compute means, SEM and t 
values. Confidence 1 imits (i.e. p values) were derived 
from standard tables. 
To analyze the entire pool of threshold data, a two 
way analysis of variance CANOVA) was performed. This 
analysis was capable of determining the significance of 
the overall drug effect on VTT, effect of the daily 
injection process and the interaction of the two. The 
least significant difference (LSD) was then calculated 
from the ANOVA so that multiole comparisons between 
groups could he made. 
Linear regression analysis was also performed on 
dose-response data and on time-response data to determine 
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trends from different experiments. Regression analyses 
were performed either by the 01 ivetti Programma or the 
University of Rhode Island IBM computer. · Anova was also 
performed by the STATPACK program of the IBM computer. 
Justification of Methods 
~ VTT ~.fill Estimate of Vulnerability 
As discussed in the Literature Review (Assessment of 
Vulnerability to Ventricular Fibrillation), the 
ventricular fibrillation threshold provides an accurate, 
reproducible method for assessing susceptibility to 
dysrhythmia. Its use dates back to 1859, and there have 
been a plethora of studies since then discussing 
variables which might alter threshold. Furthermore, in 
the study by Bell et tl ~ (1972) where the effect of 
caffeine on vulnerability to arrhythmia was examined, VFT 
thresholds were measured. To facilitate direct 
comparisons, threshold measurements were made in this 
study. Rat heart 
electrocardiographic 
does not fibrillate, according to 
definition. Thus, VT threshold was 
measured as an index of susceptibility to fibrillation in 
larger hearts. Estimation of vulnerability to vr- by 
del iverin~ subfibrillatory currents have also been 
proposed by Lown and Verrier (1 976). With increasin g 
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current intensity to the dog's ventricle, single 
repetitive extrasystoles, multiple extrasystoles, VT and 
finally VF were produced. 
The train of pulses Method of measuring VTT was 
particularly 
for testing 
considered 
alteration 
encroaching 
suited to this research, as tTme required 
is relatively short. This advantage was 
crucial to the study of any rapidly chan g ing 
in threshold. To prevent the train from 
the protective zone of the cardiac cycle, it 
was necessary to pace the heart at supranormal rates. 
To prevent the progressive increase in threshold 
with time, non-polarizable electrodes (Pt and Ag- Ag Cl) 
were used. Fibrillation was prevented (it ls not found 
in rat) and test currents were delivered no more 
frequently than once each 6-10 beats. Furthermore, VTT 
was measured trom right ventricular sites rather than 
from the left ventricle. The right ventricle tends to be 
more vulnerable to electrically induced arrhythmia than 
is the left (Shumway g-1 ~ 1g57). Thus, smaller 
stimulating currents could be utilized. The use of the 
train rather than the single pulse method also results in 
smaller thresholds and therefore reduces dama ge to the 
myocardium. 
Urethan was chosen as the anesthetic for use in 
these VTT studies, because it has mini~al effects on 
autonomic nervous system activity or the cardiovascular 
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system. Barbiturate anesthesia tends to fncrease vagal 
actfvity. Since vagal activation reduces vulnerabf 1 ity 
in the presence of increased sympathetic tone, this 
anesthetic was not used for VTT determinations. 
Furthermore, barhitone has been shown to reverse and 
prevent cardiac arrhythmia assocf ated wlth 
intracerebroventricular caffeine injection (Dikshit, 
1934). 
1L.. Use of .t.lJ.g_ Rat .2...?. .th.g_ Experimental Species 
Rats served as experimental subjects in these 
experiments. The laboratory rat has certain traits which 
makes it attractfve for studies such as this. They 
spontaneously revert to normal sinus rhythm follow i ng VT. 
This characteristic obviates the necessity of high energy 
deftbrillation. · Rats are also inexpensive to purchase 
and maintain. Thus, large numbers of animals can be 
studied. 
of the 
Genetic variance between laboratory bred rats 
same strain are minimal. The rat is also easf ly 
injected per os. All of these characteristics makes the 
rat an attractive laboratory animal for this 
investigation, when compared wit h the dog . Alt hough · dogs 
have been classically used to study vu l nera b ility to 
fibrillation, practical consi derations 1 im ited the i r use 
here. 
Ventricular fibrillation threshol ds and vulnerable 
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period measurements have been made in isolated perfused 
rat heart (Lubbe .!ti.~ 1975). Results from that study 
support the use of the rat heart as a convenient and 
reproducible test system for estimating VFT and 
vulnerable period characteristics. 
~Caffeine Administration 
The intent of this study was to examine the effects 
of caffeine on cardiac vulnerability to VF. The doses of 
caffeine were chosen to grossly mimic doses consumed by 
humans. Because of differences in pharmokinetics and 
pharmacologic dose-response effects, the dose normally 
consumed hy humans was increased by a factor of ten Con a 
mg/kg basis} for injection Into the rats. This 
conversion factor is a common value compar i ng the toxic 
effects of drugs in rat and in man. An estimated lethal 
dose of ca ff e i n e i n man i s 1 O gm ( R i t ch i e , 1 9 7 5 } , 
whereas, the LD of oral caffeine administration has 
been reported to be 330 mg/ kg (Bond il .2.L.....c.. 19i3). 
Assuming a human weight of 70 kg, the lethal dose of 10 
gri v-1as equivalent to 11~3 m,g/kg. However, this human 
lethal dose is most certainly not an LD , nor for . that 
matter is it an LO It is simply a dose reported from 
a case study (unreferenced by Ritchie) that was lethal 
followin g oral ingestion. As a result, it is difficult 
to compare the lethal dose in human with that in the rat. 
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The range of doses chosen to be administered to the 
rats on a chronic basis was large enough such that any 
possible effect which caffeine might have would he 
expected to be evident. Dose-response data from single 
injections of caffeine supported the choice of 10, 30 and 
90 mg/kg. The lowest dose caused no appreciable effect, 
whereas the two higher doses produce similar effects when 
given acutely. Treatment for ten weeks was chosen as the 
maximal length of study. Shorter periods of study were 
also undertaken, but no longer studies were carried out. 
Again, it was arbitratily decided that any effect of long 
term caffeine treatment would at least start to become 
evident after 10 weeks of injections. 
Challenge treatments, i.e. oral drug 
administrations immediately prior to VTT testing, were 
performed in all groups. The rationale for acute drug 
administration in the long term treatment groups was to 
allow for direct comparison of the acute drug effect 
between two different treatments; 
chronically treated animals • 
.IL.. lsoproterenol Dose Response Curves 
i.e. naive and 
lsoproterenol increases heart rate by stimulation 
of beta-adrenergic receptors. Direct activation of 
cardiac heta receptors causes tachycardia. In addition, 
the hypotensive action of the drug will elicit a 
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baroreceptor reflex mediated Increase in sympathetlc tone 
to the heart. 
The 
adrenerglc 
ch ron i cal l y 
sensitivity of 
st i mu l at i on was 
with caffeine. 
the cardiac beta receptors to 
examined in rats treated 
Caffeine has been shown to 
activate the the beta adrenergic receptor (see Literature 
Review). Specifically, the action of caffelne in 
reducing the VFT in dogs (Bel let .tl tl-c. 1'372) v"as shown 
to be hlocked by propranolol and practolol. As a result, 
any effect of chronic caffeine treatment on subsequent 
VTT would logically be thought to be mediated by thls 
catecholaminergic system. Adrnlttedly other, more complex 
mechanisms can be envisioned. Examination of the cardiac 
beta receDtor sensitivity was the most reasonable first 
step in elucidating a mechanism of action. 
~Statistical Analysis 
Because of the combination of variables being 
examined (i.e. drug treatment at different doses and oral 
injectlon for different times) the two way analysls of 
variance was used to quantltate the variance of the VTT 
data and the significance of the effects of these 
variables on VTT. Within a particular experiment, 
however, the Student's t test was more sensitive to 
changes in threshold and was therefore applied. The 
Student's t test is designed to test the ability of a 
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single treatment to alter the parameter under study. 
Withfn a given experiment (i.e. acute caffeine~ acute 
water treatment) all animals were housed together, 
treated over the same time period and tested on 
successive days. Thus, except for the specific 
treatment, all variables which might cause a difference 
in thresholds between the two groups were minimized. The 
Student's t test was therefore considered to more 
accurately reflect differences between two groups within 
a given experiment than the analysis of variance. 
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RESULTS 
Introductory Remarks 
Twenty-three groups (6 rats/group) were tested for 
vulnerability to ventricular tachyarrhythmia. Four of 
those groups were given only an acute single oral 
injection (either water or caffeine; 10, 30 or 90 mg/kg) 
prior to threshold measurement. In nineteen groups, 
daily oral 
administered 
administration of one of these solutions was 
prior to the test day, at which time the 
solution was injected (p.o.) just prior to VTT 
testing. In one group caffeine was administered for 10 
weeks (90 mg/kg/day), but the rats were challenged with 
distilled water immediately before vulnerability testing. 
Finally, one group was given no treatment prior to 
anesthesia and VTT determination. 
Of the 138 rats initially included in the VTT 
study, no data was recorded from eight. Two chronically 
treated rats died immediately following an oral 
administration of caffeine. Death followed violent major 
motor seizures. Three other rats died from anesthesia at 
the time of VTT testing, and two animals who had severe 
respiratory infection were discarded from the sturly. All 
those animals who were not included in the study were 
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from different treatment groups, with the exception of 
two rats from the 10 week, 30 mg/kg caffeine treated 
group. Based on the mean and standard error of the mean, 
calculated VTT's for the missing animals were generated 
so that the mean and standard error of the group would be 
minimally affected. 
Initial experiments on VTT measurement suggested 
that VTT increased with time following urethan anesthesia 
(Figure 7). Alternatively this progressive elevation in 
threshold could have been the result of repetitive 
electrical discharges to the heart during testing. This 
possible explanation was investigated by examining the 
correlation between initial determination of VTT and time 
following anesthesia. The data presented in Figure 8 
shows that there was no significant correlation between 
these parameters. Since these results suggest that 
threshold did not increase with time following 
anesthesia, no detailed analysis was subsequently 
performed · of the time at which threshold was measured. 
However, in 1 ight of the progressive rise in VTT, in the 
remainder of the study the VTT was taken to be the first 
threshold value recorded. 
A two-way analysis of variance (caffeine dose and 
treatment duration versus VTT) demonstrated that both of 
these parameters altered threshold (p <0.05). Based on 
the knowledge that each factor was responsible for a 
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Fieure 7. Progressive Elevation In VTT Following 
Anesthesia 
VTT was measured at 5 minute intervals. Both the 
caffeine treated and untreated rat demonstrated a 
progressive elevation in VTT with repeated 
testing. 
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change in VTT, and the realization that the effect of 
acute caffeine administration was totally different from 
the long term effect, the results were analyzed in two 
sections. In the first, alterations in VTT by acute drug 
administration are presented. In the second, chronic 
drug effects are examined. 
Effect of Acute Caffeine Treatment 
Single, acute, oral 
caffeine reduced VTT from 
control animals (Figure 9). 
reduction in threshold (p 
Injections of either water or 
that measured in untreated 
Water injection caused a 35% 
<O.l), but caffeine 
administration produced an even greater effect than that 
seen with injection of the vehicle. The reduction in VTT 
by caffeine injection did not reach statistical 
significance (p >0.05) when administered at 10 mg/kg. 
With larger doses (30 and 90 mg/kg) thresholds were 
significantly reduced. However, increasing the dose from 
30 to 90 mg/kg caused no further reduction in VTT. The 
maximal change in threshold with acute caffeine treatment 
was a 52% decrement. 
To differentiate the caffeine effect on VTT from 
that of the oral injection process, caffeine treated 
groups were compared with water treated controls. Mean 
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Figure 8. Correlation of Initial VTT Wlth Time After 
Anesthesia 
Initial VT thresholds following an oral injectfon 
and subsequent anesthesia are shown not to be 
correlaterr with the interval between anesthesia 
administration and VTT determination. This data 
is from rats treated with water for 10 wee~s. 
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Figure 9, Effect of Acute Caffeine Injection on VTT 
VTT threshold following a single oral Injection 
(2m1/kg) of water or caffeine. Values are mean~ 
SEM for 6 rats/group. Treatment with caffeine at 
30 or 90 mg/kg significantly reduced VTT when 
compared to water treated rats (stripped bar) (p 
<O.l). 
90 
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threshold in drug treated animals (90 mg/kg) was 75% of 
their water treated counterparts (p <O.l). Caffeine 
administered at a dose of 30 mg/kg produced a similar 
reduction whereas the 10 mg/kg dose caused only a small 
change (-9 %) • 
Acute caffeine administration also produced a dose 
related tachycardia. Water treated rats had an initial 
heart rate (i.e. after anesthesia, thoracotomy and 
electrode placement) of 236 ~ 11 beats per minute. In 
caffeine treated rats (10, 30 and 90 mg/kg) heart rate 
was increased to 274 + 12 beats per minute, 292 + 43 
- -
beats per minute and 292 + 29 beats per minute 
respectively. The fact that the 2 1 a r ge r doses of 
caffeine had the same effects on both heart rate 
elevation and VTT reduct.ion should be noted. 
Effect of Daily Caffeine Treatment on VTT 
~Chronic Caffeine Treatment Altered the Effect of Acute 
Caffeine Challenie on VTT 
This sub-section will present results only . from 
groups of rats treated with the~ solution prior to 
and on the day of VTT testing. The combined effect of 
chronic caffeine pretreatment and acute water challenge 
on threshold will be presented in the following 
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sub-section of results. 
Daily oral injections with caffeine (90 mg/kg) for 
periods of 8 or 10 weeks produced an increase in 
threshold as compared with their water treated 
counterparts (Figure 10). There was no difference 
between thresholds of animals treated for 2 or 4 weeks, 
but rats treated with caffeine for 8 or 10 weeks had 
thresholds more than twfce as large as those treated with 
water (p <O.l and p <0.01 respectively). This 
progressive fncrease i~ threshold with progressively 
longer treatments was not seen with smaller doses of 
caffeine. 
Following 8 or 10 week treatment, the relative 
increase in VTT seen with caffeine administration was 
dose re~ated. For example, following 8 weeks of 
treatment at 10 mg/kg, caffeine elevated the threshold by 
29 % as compared to the group treated wit h water for the 
same ti me period. At a dose of 30 mg/kg , the elevation 
was 60 % greater than control values. With the hi ghest 
dose of caffeine rats yielded VTT's some 2.4 times 
greater than their water treated counterparts. The 
dose-response effect of subchronic caffeine treatment on 
subsequent VTT measurement is presente d i n Fi gure 11. 
There was no dose dependent trend in t he effect of 
chronic caffeine treatment on heart rate. Two way 
analysis of variance on all of t he heart rate data also 
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Figure 10. Reversal of the Effect of Acute Caffeine 
Injection on VTT Following Daily Caffeine Treatment 
VTT thresholds of rats treated with caffeine (90 
mg/kg/day) were compared with rats treated with 
water for the same periods of time. Single acute 
treatment is labelled as 1 0 weeks 1 • Caffeine 
treated rats were challen ged with caffeine. Water 
treated rats were challenged with water, Means+ 
SEM for groups of 6 rats. 
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substantiated that the duration of caffeine treatment 
(i.e. acute~ chronic) caused no significant change in 
heart rate. 
The VTT results just presented are in dramatic 
contrast to the effect of single, acute caffeine 
injections on threshold. The blphasic alteration ln 
threshold was seen in Figure 10, where caffeine (90 
mg/kg) caused a reduction in threshold when given acutely 
(25 %), but increased threshold (by more than 100 %) when 
administered daily for 8 or 10 weeks. Two of four week 
treatment annulled the acute reduction in threshold 
caused by caffeine challenge treatment, but did not 
produce any increase in VTT over control values. The 
chronic treatment-induced reversal of caffeine's 
arrhythmogenic action is summarized in Figure 12. The 
dose dependent increase in 
treated g roups is clear. 
VTT with increasing doses 
threshold in the chronically 
The progressive reduction in 
of acutely administered 
caffeine cannot be shown to be rlose dependent (re g ression 
coefficient = 0.2). As mentioned earlier, analysis of 
variance was performed on the thres hold data to test 
whether the dose of caffeine had a si gnificant effect, 
whether the duration of treatment altere d VTT and whether 
there was any interaction between the two variables. The 
results of the test, p resente d in Ta b le IV demonstrate 
that both factors alter threshold in and of themselves, 
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Figure 11. Dose Dependency of Chronic Daily Caffeine 
Treatment on Subsequent Elevation of VTT 
96 
Daily oral caffeine administration for 8 or 10 
weeks followed by an acute caffeine challenge was 
associated with an elevation in VTT. The increase 
ln VTT was dose related. (Data pooled from 8 and 
10 week treatment groups). 
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Figure 12. The Effect of Acute~ Chronic Caffelne 
Treatment on VTT 
+ VT thresholds of rats treated daily with 
caffeine for 10 weeks. Prior to VTT determination 
each rat received a challenge injection of the 
same caffeine dose administered previously. 
o VT thresholds of rats administered a singl e 
injection of water or caffeine just prior to VTT 
determination. 
Each point is the mean threshold of 6 rats. 
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TABLE l.Y. 
Analysis Of Variance Of The Effects Of Caffeine 
Treatments For Different Time Periods On VTT 
Source Sums Degrees 
of of of Mean 
Vari at l on Squares Freedom Squares 
Caffeine 
Treatments* 828 3 273 
Weeks of 
Treatment** 98 6 3 329 
Treatment by Week 
Interaction 1766 9 196 
Error 2199 80 27 
Total 5773 95 
* Water or caffeine (10, 30, or 90 mg/kg) 
* * Ac u t e o r 4 , ·a , o r 1 O wee ks 
F p 
Values Values 
9.97 <0.05 
11.96 <0.05 
7.14 <0.05 
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TABLE V 
Summary of VTT Data and 
LSD Test of Significant Differences 
CAFFEINE 
DOSE 
0 
10 
30 
90 
VTT 
0 
8. 8 
.!. 1.0 
8. 0 
.!. 1.1 
6.5 
.!. 1.2 
6.6 
+ 0. 8 
* Mean s.!. SEM of 6 rats. 
Jn m Afc1PS 
4 
12.2 
+ 2.1 
9.5 
+ 2.1 
12.7 
.!.. 1. 5 
10.7 
+ 1.4 
* 
8 10 WEEKS 
5.2 6.2 
+ 0.6 
-
+ 0.6 
6.7 6.2 
.!. 0 . 7 .!. 1.0 
8.3 10.0 
.!. 1.0 .!. 2.2 
12.5 32.0 
+ 
-
4.3 + 4.8 
Least Significant Difference (LSD) = s(l/n:t + 1/n 'E i;; t 
where s = (mean square of ANOVA error term) 
n1 and n2 =· number of rats in the experimental groups 
being compare<l. t = t value; chosen in this case as the 
value at which a 95% confidence 1 imlt is assumed and the 
degrees of freedom is equal to the sum of the degrees of 
freedom minus that of the error term (i.e. 15). 
Thus, 
LSD = 5.2424 x 0.577 x 2.131 = 6.45 
Threshold values which differ by more than 6.45 m AMP are 
significantly different (p <0.05) according to this test. 
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and that they also interact in some additive fashion. 
The least significant difference was calculated from the 
analysis of variance data and applied to analyze 
differences in VTT between groups (Table V). Again, 
following 8 and 10 weeks of treatment, caffe i ne (90 
mg/kg) increased the VTT. 
!h_ The Effect of Chronic Caffeine Treatment Combine d With 
Ac u t e \·J a t e r Ch a 1 1 en g e .Q.Il VT T 
VT thresholds were determined in 3 groups of rats. 
Two groups (A and B) received chronic daily caffeine 
treatment (90 mg/kg/day, p.o.) and the third (group C) 
received water injections each day. Followin g the ten 
week treatments, one chronic caffeine group was 
challenged with a bolus of caffeine (90 mg/kg, p.o.), 
while the other (group B) was administered water prior to 
cardiac vulnerability testing. The chronic water treated 
group (C) was also challenged with water. 
In both groups A and B, threshold was elevated when 
when compared with the VTT of rats treated chronically 
with water (group C). The increase In VTT in Group A was 
138 % and in Group B, 89 %. The elevations in threshold 
demonstrated in the two chronic caffeine treated g roups 
were not si gnificantly different from each other. Thus 
chronic caffeine was associated wit h a si milar increase 
in VTT whether the rat was challen ged with caffeine or 
\'later. 
Effect of Chronic Caffeine Treatment 
on I sop rote reno 1 Induced Ta ch yea rd i a 
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After treatment for 10 weeks with caffeine (90 
mg/kg) rats tended to show an attenuated increase in 
heart rate with increasing doses of isoproterenol. This 
effect, demonstrated in Figure 13, was only evident at 
the highest doses of isoproterenol. Each point on the 
curve represents the results of only 4 rats - two 
caffeine treated and one chronic water treated animal had 
died prior to testing. A second water treated rat dfd 
not show a dose dependent tachycardia and was therefore 
not included in the study. 
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Figure 13. Alteration of lsoproterenol Chronotropy By 
Chronic Caffeine Pretreatment 
Rats were treated with oral 
or water for 10 weeks. 
vagotomy, each animal was 
doses of isoproterenol. 
rats/group. 
injections of caffeine 
Following bilateral 
tested with increasine 
Mean + SE M, n = 4 
6 .0 
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DISCUSSION 
The results of these experiments indicate that oral 
caffeine administration alters the vulnerabil lty of rat 
ventricle to tachyarrhythmia. In agreement with the 
findings of Bellet and coworkers (1972), acute injecti on 
of the drug (90 mg/kg) reduced the threshold to 
arrhythmia. The dose dependent tachycardia associated 
with single caffeine injection suggests a correlation 
between elevation of sympathetic tone to the periphery 
and caffeine - induced reduction in VTT. This assessment 
is also in agreement with the finding that beta 
adrenergic blockade prevented the acute reduction in 
threshold by caffeine (Bel let et~ 1972). 
The oral injection of water was also associated 
with a reduction in VTT. The magnitude of the reduction 
was significantly less than that associated with caffeine 
ingestion. Thus the caffeine related reduction in 
threshold was in addition to that caused by the injection 
process. 
The acute injection process may be associated with 
a reduced threshold as a result of a generalized stress 
reaction. The effect of stress in au gmenting cardiac 
vulnerability has previously been demonstrated by Lown _g_t 
£..L. (1973) and Corhalan _g_t £..L. (1971~). The threshold for 
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repetitive response was reduced to 67% of control values 
when dogs were placed in a stressful envlronment. 
Selective beta-1 adrenergic blockade with tolamolol 
hydrochloride prevented this reduction in threshold 
associated with psychologic stress (Lown ~nd Verrier, 
1976). Increased ventricular vulnerability in the 
setting of 
sympathetic 
increased 
stress thus appears to also be mediated by 
nervous system activity. Sympathetlc tone, 
as a result of the injection process, would be 
further augmented by caffeine administration. This 
combined activation of the sympathetic 1 imb of the 
autonomic nervous system seems to mediate the additive 
reduction in VTT by caffeine and the Injection process. 
The reduction in VTT following a single caffeine 
injection is maximal at a dose of 30 mg/kg. The 
tachycardic effect of acute oral caffeine administration 
is also maximal at this same dose. At 10 ~g/kg, caffeine 
does not significantly alter either of these parameters. 
Rough conversions of these doses to human equivalent 
doses (with rat considered one tenth as sensitive as man) 
suggest that the caffeine content of as 1 ittle as 2 cups 
of coffee may increase the vulnerability of the human 
heart to arrhythmia. A more conservative estimate of the 
conversion factor Ci .e. no difference in sensitivity) 
would predict that this dose in rat represents that found 
in 21 cups of coffee (30 mg/kg X 70 kg body wei gh t /100 
mg/cup). Based 
by Vitello and 
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on the rough conversion factor reported 
Woods (1975), this dose represents the 
caffeine content in 10-15 cups of coffee. 
Daily subacute administration of caffeine (for 2 or 
4 weeks) prevented the reduction in VTT associated with 
caffeine injection just prior to threshold measurement. 
Tolerance occurs to many effects of the drug (see 
Literature Review). In a similar manner subacute 
administration of caffeine may make the rat tolerant to 
the VTT reducing action of caffeine. Four week treatment 
with oral water injections produce rats whose thresholds 
are the same as untreated controls (Table V). Thus 
tolerance has developed to the injection process as well. 
Stress adaptation may play a part in this 
demonstration of tolerance to the effect of the injection 
process and caffeine administration on ventr i cular 
vulnerability. Following 32 days of restraint stress, 
male albino rats demonstrated adaptation to the effects 
of stress on brain serotonin content, norepinephrine 
content, blood corticosterone levels, and various organ 
weights (Rosecrans and De Feo, 1965). The physical and 
psychologic stress related to the inject i on process may 
well be the same as that associated wi th restraint 
stress. The action of caffeine administrat i on to 
increase brain norepinephrine turnover rates and decrease 
brain serotonin rates (see Literature Revie w), would be 
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construed as Increases in brain serotonin levels and a 
reduction in NE levels - i.e. the same effects associated 
with restraint stress (Rosecrans and De Fee, 1965). Thus 
caffeine administration may, to a certain extent, be 
interpretted as producing a stress reaction. Tolerance 
to the effect of caffeine on VTT may therefore be due to 
pharmacologic tolerance (i.e. the increased metabolism 
and excretion or decreased effect of the drug at the 
receptor) and/or adaptation to stress associated with 
caffeine administration. 
Subchronic caffeine treatment (90 mg/kg/day) for 8 
or 10 weeks was associated with a t wo fold increase in 
VTT when compared with that of control rats treated with 
oral water injection for the same periods of time (Fi gure 
10). Smaller doses of caffeine produced correspon d in g ly 
less elevation in threshold (Figure 11). This reversal 
of the VTT reducin g effect of acute caffeine i nj ection 
suggests that chronic caffeine administration causes some 
radically different effect than does the acute or even 
subacute administration of the dru g . This effect of 
chronic caffeine administration on vulnerability cannot 
be interpreted merely as tolerance, since to l erance 
implies compensation which prevents t he a gent from 
producing its normal effect. In this case caffeine 
produces an elevation in VTT, re gard l ess of t he challen ge 
dose, thus suggestin g an effect which is just the 
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opposite of that seen with single injection. Chronic 
administration may reduce cardiac vulnerability by 
altering certain receptor sites. 
Chronic caffeine treatment was shown to reduce the 
maximal chronotropic effect of lsoproterenol, but not to 
shift the dose-response curve (Figure 13). 
Interpretation of these findings suggest that there is no 
reduction in the sensitivity of the cardiac beta 
adrenergic receptor. Such an effect would be reflected 
as a shift to 
Conversely, the 
the right of the dose response curve. 
reduction in the maximal effect of 
isoproterenol on heart rate suggests that there has been 
a reduction in the beta receptor population mediating 
i sop rote reno 1 induced tachycardia. 
Reduction in cardiac beta receptor population could 
explain the demonstrated elevation in VTT. Wi thdrawal of 
sympathetic tone 
to fibrillation 
to the heart reduces its vulnerability 
(see review by Lown et~ 1977). The 
reduction on cardiac beta receptor concentration would be 
equivalent to an anatomical and functional reduction of 
tonic sympathetic input 
that this mechanism is 
to the heart. The conclusion 
the only explanation of the 
chronic caffeine related elevation in threshold cannot be 
made based on the 
number of rats in 
results of this study. The 1 imited 
the isoproterenol dose response 
experiment were too few to demonstrate statistical 
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significance of the data trend. More importantly, other 
sites or mechanisms of action of caffeine may also reduce 
cardiac vulnerability. Speculation as to possfble 
additional mechanisms could include at least the 
followfng: increased vagal traffic as a result of 
caffeine's actions on midbrain vagal centers or increased 
phosphodiesterase activity (due to induction of new 
enzyme formation) resulting in reduced c AMP levels 
within the heart. Both of these effects would reduce 
vulnerability to VF according to presently held theories 
(see Literature Review). 
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SUMMARY AND CONCLUSIONS 
Clinical studies examining the correlation of 
coffee consumption on incidence of acute Ml and 
subsequent death (presumably the result of VF) have 
failed to clearly examine the effect of caffeine on 
vulnerability to VF. One previous laboratory study 
(Bel let~~ 1972) demonstrated that caffeine infusion 
(12.5 mg/kg, i.v.) reduced fibrillation threshold. 
Again, such a study does not directly determine the 
effect of chronic .QL£.l caffeine administration, i.e. the 
manner in which caffeine is consumed by man, on the 
susceptibility to 1 ife-threatening dysrhythmia. 
This study represents the first reported laboratory 
experiments examining the effects of daily oral caffeine 
administration on cardiac vulnerability to ventricular 
tachyarrhythmia. The effects of acute and chronic oral 
administratio'n of caffeine on the ventricular tachycardia 
threshold was determined. The VTT in rat was proposed as 
an index of the vulnerability of larger hearts to 
f i b r i 1 1 at i on • 
The results of this investi gation suggest that a 
single, oral injection of caffeine (30 or 90 mg/kg ) 
increases susceptibility of the heart to arr hythmia. The 
caffeine effect is in addition to the general stress 
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effect of the oral injection process. The map;nitude of 
the effect is similar to that demonstrated by Bellet and 
coworkers. Dose related tachycardia accompanied the fall 
in VTT suggesting 
the periphery. 
a heightening of sympathetic tone to 
for 8 
In marked 
or 10 
contrast, daily caffeine administration 
weeks followed by the same acute test 
injection was associated with a greater than two fold 
increase in VTT when compared with water treated 
controls. This reversal of acute drug effect was dose 
dependent. Following 2 or 4 week caffeinetreatment, 
acute caffeine injecvtion no longer reduced VTT. 
In an attempt to explain these results, this study 
indicated that chronic caffeine administration tended to 
attenuate the maximal chronotropic effect of 
isoproterenol. However, this tendency was not 
demonstrated with certainty, because statistical 
significance was not reached (presumably due to the small 
number of subjects). The effect of long term caffeine 
treatment may be to reduce the beta adrenergic receptor 
population in the heart and/or brain. 
It is concluded that single caffeine 
administration, 
by man in 6-8 
suscent i bi 1 i ty 
tachya r rhythm i a. 
at doses corresponding to that consumed 
cups of g round coffee, increased the 
of rat heart to ventricular 
Pretreatment for 8 or 10 weeks with 
similar caffeine 
susceptibility to 
protective effect 
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doses prevented the increased 
arrhythmia and, in fact, had a 
by reducing the vulnerability to life 
threatening arrhythmia. 
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